<!DOCTYPE html>

<html lang="en">
<!--[325694|cc|]--><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>Zytiga: Side effects, cost, dosage, and more</title>
<meta property='og:url' content='https://www.medicalnewstoday.com/articles/325694.php'/>		<meta property="og:type" content="article"/>
		<meta property="og:site_name" content="Medical News Today"/>
		<meta property="og:title" content="Zytiga: Side effects, cost, dosage, and more"/>
					<meta property="og:description" content="Zytiga (abiraterone acetate) is a brand-name prescription medication. It’s used to treat two types of prostate cancer: metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC). Zytiga comes as a tablet. Learn about side effects, cost, dosage, and more."/>
			<meta name="description" content="Zytiga (abiraterone acetate) is a brand-name prescription medication. It’s used to treat two types of prostate cancer: metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC). Zytiga comes as a tablet. Learn about side effects, cost, dosage, and more."/>
						<meta property="og:image" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
					<meta property="fb:admins" content="1658973110"/>
		<meta property="fb:app_id" content="147184211975697"/>
					<meta itemprop="description" content="Zytiga (abiraterone acetate) is a brand-name prescription medication. It’s used to treat two types of prostate cancer: metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC). Zytiga comes as a tablet. Learn about side effects, cost, dosage, and more."/>
						<meta itemprop="image" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
					<meta name="twitter:domain" content="medicalnewstoday.com"/>
		<meta name="twitter:card" content="summary_large_image"/>
		<meta name="twitter:site" content="@mnt"/>
		<meta name="twitter:title" content="Zytiga: Side effects, cost, dosage, and more"/>
					<meta name="twitter:description" content="Zytiga (abiraterone acetate) is a brand-name prescription medication. It’s used to treat two types of prostate cancer: metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC). Zytiga comes as a tablet. Learn about side effects, cost, dosage, and more."/>
					<meta name="twitter:creator" content="@mnt"/>
					<meta name="twitter:image:src" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
			<META name="rating" content="general">
<META http-equiv="Cache-Control" content="no-cache">
<meta name="p:domain_verify" content="ca332f19ebf583ba72eff99cc210a982"/>
<meta name="msvalidate.01" content="65DAC77377665AE872AC660E37807BC6" />
<META http-equiv="bulletin-text" content="Copyright">

			<link rel="canonical" href="https://www.medicalnewstoday.com/articles/325694.php">
			
<link rel="shortcut icon" type="image/png" href="https://cdn-prod.medicalnewstoday.com/favicon.png">
<link rel="icon" sizes="32x32" href="https://cdn-prod.medicalnewstoday.com/favicon.ico">
<link rel="apple-touch-icon" type="image/png" href="https://cdn-prod.medicalnewstoday.com/apple-touch-icon.png">

	<link rel="alternate" type="application/rss+xml" title="Medical News Today - Health News Headlines RSS Feed" href="https://rss.medicalnewstoday.com/featurednews.xml">
	<link rel="alternate" type="application/json" title="Medical News Today - Health News Headlines JSON Feed" href="https://rss.medicalnewstoday.com/json/featurednews.json">
	
<meta http-equiv="x-dns-prefetch-control" content="on">
<link rel="preconnect dns-prefetch" href="//cdn-prod.medicalnewstoday.com" crossorigin>
<link rel="preconnect dns-prefetch" href="//cdn2.medicalnewstoday.com" crossorigin>


	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff2">
	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-Light.woff2">
	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-Regular.woff2">


	<style>
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff') format('woff');
			font-weight:900;
			font-display: swap;}
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-Light.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-Light.woff') format('woff');
			font-weight:200;
			font-style:lighter;
			font-display: swap;}
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-Regular.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-Regular.woff') format('woff');
			font-weight:400;
			font-weight:normal;
			font-style:normal;
			font-display: swap;}

		@font-face {
			font-family: 'ProximaNova';
			src: url('https://cdn-prod.medicalnewstoday.com/structure/fonts/ProximaNova/ProximaNova-Bold.woff2') format('woff2'),
			url('https://cdn-prod.medicalnewstoday.com/structure/fonts/ProximaNova/ProximaNova-Bold.woff') format('woff');
			font-weight:600;
			font-weight:bold;
			font-style:bold;
			font-display: swap;}

		@font-face {
			font-family: 'Arnhem';
			src: url('https://cdn-prod.medicalnewstoday.com/structure/fonts/Arnhem/ArnhemPro-Bold.woff') format('woff');
			font-weight:600;
			font-weight:bold;
			font-style:bold;
			font-display: swap;}
	</style>





	
<link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN" crossorigin="anonymous">

					<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_default_redesign_7721.css?v=190904" type="text/css" media="all" />
		

		



					<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_print_redesign_7721.css?v=20181203" type="text/css" media="print">
				
		


<!--[if lt IE 9]>
<script src="//html5shim.googlecode.com/svn/trunk/html5.js"></script>

			<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_ie.css" type="text/css" media="all" />
	


	<![endif]-->
<!--[if IE 7]>

<script src="//ie7-js.googlecode.com/svn/version/2.1(beta4)/IE7.js"></script>
<![endif]-->	
<!--[if IE 9]>
<script src="//ie7-js.googlecode.com/svn/version/2.1(beta4)/IE9.js"></script>
<![endif]-->


<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.2, maximum-scale=2.0, user-scalable=1"><!--desktop-->


<noscript>
<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/styles_noscript.css" type="text/css" media="all" />	
</noscript>
<script type="text/javascript" >
			var glob_mntcookie = 1;
	  </script>
<script>

glob_JS=(typeof glob_JS === 'undefined')?{'GAInit':[],'GA':[],"ExternalJS":[],"AD":[]}:glob_JS;

glob_TrueOnGDPR=(glob_mntcookie!=1);

//if use GDPR is true, we need this flag to make sure ga queue can ber execute after ga is ready
glob_isGaReady=!glob_TrueOnGDPR;



if(typeof fireOrSaveGoogleAdFunctions === 'undefined'){



    function fireOrSaveGoogleAdFunctions(adFunction){

        if(!glob_TrueOnGDPR){

            adFunction();

        }else{

            if(typeof fireOrSaveGoogleADs === 'undefined'){
                //save ad event in queue
                glob_JS.AD.push(adFunction);
            }else{
                //let next function to determine save or fire ad function
                fireOrSaveGoogleADs(adFunction);

            }
        }

    }

    function fireOrSaveJsFunctions(jsType,jsFunction){

        if(!glob_TrueOnGDPR && jsType!=0){
            //if GDPR already accept, and func type is not ga event, just exec

            jsFunction()

        }else if(!glob_TrueOnGDPR && jsType===0) {
            //for ga event only

            if(glob_isGaReady) {
                //if ga ready, call the function
                jsFunction();
            }else{
                //if user accept GDPR, but ga not ready, still push new command into queue
                glob_JS.GA.push(jsFunction);

            }

        }else{

                if(jsType<0){
                    jsType='GAInit'
                }else if(jsType==0){
                    jsType='GA';
                }else{
                    jsType='ExternalJS';
                }

                if(typeof fireJS === 'undefined'){
                    //save ad event in queue


                    if(jsType=='GAInit'){

                        glob_JS.GAInit.push(jsFunction);

                    }else if(jsType=='GA') {

                        glob_JS.GA.push(jsFunction);
                    }else
                    {
                        //default is other js
                        glob_JS.ExternalJS.push(jsFunction);
                    }


                }else{
                    //let next function to determine save or fire ad function
                    fireJS(jsType,jsFunction);

                }
            }
    }



    function loadScript(url, parameters,callback){



        var script = document.createElement("script");
        script.type = "text/javascript";


        //add custom attribute
        for (var key in parameters) {
            if (parameters.hasOwnProperty(key)) {
                script.setAttribute(key,parameters[key]);
            }
        }


        if (script.readyState){  //IE
            script.onreadystatechange = function(){
                if (script.readyState == "loaded" ||
                    script.readyState == "complete"){
                    script.onreadystatechange = null;
                    callback();
                }
            };
        } else {  //Others
            script.onload = function(){

                if(typeof callback === 'function'){
                    callback();
                }

            };
        }

        script.src = url;
        document.getElementsByTagName("head")[0].appendChild(script);
    }



}

</script>




<!--<script type='text/javascript'>
(function() {
var useSSL = 'https:' == document.location.protocol;
var src = (useSSL ? 'https:' : 'http:') +
'//www.googletagservices.com/tag/js/gpt.js';
document.write('<scr' + 'ipt src="' + src + '"></scr' + 'ipt>');
})();
</script>-->


<script type="text/javascript">
	//CMP	
 	var isEEA = false;
 	var passEEACheck = false;

	var metadata = 'BOSk20WOSk20WABABBENBR-AAAAeCAFAAUABwAEAANABCA';
	var purposeConsents = { 1: true, 2: true, 3: true, 4: true, 5: true };
	var vendorConsents = { 10:true, 28: true, 32: true, 52: true, 132: true };

		function __cmp(cmd, p, cb) {
			if (cmd === 'getVendorConsents' || cmd === 'getConsentData') {
				cb({
					hasGlobalScope: true,
					gdprApplies: isEEA,
					metadata: metadata,
					consentData: metadata,
					purposeConsents: purposeConsents,
					vendorConsents: vendorConsents
				}, true);
			} else if (cmd === 'ping') {
				cb({gdprAppliesGlobally: false, cmpLoaded: isEEA});
			} else {
				throw new Error('Invalid CMP command '+ cmd);
			}
		}
</script>
<!-- <script async src="//js-sec.indexww.com/ht/p/184901-208206248649346.js"></script> -->
<!-- <script async src="//js-sec.indexww.com/ht/p/180447-192872210293780.js"></script> -->
<script type="text/javascript">
	fireOrSaveJsFunctions(1,function(){
		(function() {
			var indexWrapper = document.createElement("script");
			indexWrapper.async = true;
			indexWrapper.type = "text/javascript";
			var useSSL = "https:" == document.location.protocol;
			indexWrapper.src = (useSSL ? "https:" : "http:") + "//js-sec.indexww.com/ht/p/180447-192872210293780.js";
			var node =document.getElementsByTagName("script")[0];
			node.parentNode.insertBefore(indexWrapper, node);
		})();
	});
</script>
<script type="text/javascript">
fireOrSaveJsFunctions(1,function(){
	window.headertag = window.headertag || {};
	window.headertag.pagetype='drugs';
});
</script>

<script type="text/javascript">
	//ADBRIDG MIGRATION: Load the Adbridg library directly after the GPT library. 
  var AdBridg = AdBridg || {};
  AdBridg.cmd = AdBridg.cmd || [];
  window.adbridgFallback = function() {
		console.log('ADBRIDG MIGRATION: library failed to load; falling back to GPT');
    var dq = [], l = [], ls = {}, lf = [], es;
    var rl = function(f) {return function(){var a=arguments, x=function(){f.apply(null,a)};lf.push(x);pl()}}
    var pl = function() {if(!l.length){while(lf.length){(lf.shift())()}}}
    dq.process = function() { while(dq.length) { googletag.display(dq.shift()); }}
    AdBridg.defineSlot = function(p, s, d) { return googletag.defineSlot(p, s, d).addService(googletag.pubads()); }
    AdBridg.defineOutOfPageSlot = function(p, d) { return googletag.defineOutOfPageSlot(p, d).addService(googletag.pubads()); }
    AdBridg.destroySlots = function(s) { return googletag.destroySlots(s); }
    AdBridg.display = function(d) { dq.push(d); if (es) { dq.process(); }}
    AdBridg.refresh = function(s, o) { googletag.pubads().refresh(s, o); }
    AdBridg.render = function() { }
    AdBridg.serve = function() { googletag.enableServices(); es=1; dq.process(); }
    AdBridg.sizeMapping = function() { return googletag.sizeMapping(); }
    AdBridg.useSizeMapping = function() { }
    AdBridg.lock = function(s) {if(ls[s]){ls[s]=null;return;}l.push(s);pl()}
    AdBridg.unlock = function(s) {var f=0; for(var i=0;i<l.length;++i){if(l[i]==s){l.splice(i,1);f=1}}; if(!f){ls[s]=1} pl()}
		AdBridg.cmd.push = function(f) {
			if (typeof(f)=='object') {
				var api_fallback = function(o) {
					googletag.cmd.push(function() {
						var fl;
						if (o.gpt_path) {
							var u=AdBridg.defineSlot(o.gpt_path,o.size||[],o.dom_id);
							if(o.size_map) {
								var m = googletag.sizeMapping();
								for(var oi=0;oi<o.size_map.length;oi++){m=m.addSize(o.size_map[oi].viewport, o.size_map[oi].sizes);}
								u.defineSizeMapping(m.build());
							}
							if(o.events) {
								if(o.events["gpt.defined"]){o.events["gpt.defined"](u);}
								fl = function(a,b){if(o.events[a]){googletag.pubads().addEventListener(b,function(e){if(e.slot===u){o.events[a](u,e)}})}}
								fl("gpt.rendered",'slotRenderEnded');
								fl("gpt.viewed",'impressionViewable');
								fl("gpt.visibilityChanged",'slotVisibilityChanged');
							}
						} else if (o.events) {
							fl = function(a,b){if(o.events[a]){googletag.pubads().addEventListener(b,function(e){o.events[a](a,e)})}}
							fl("gpt.render_raw",'slotRenderEnded');
							fl("gpt.viewed_raw",'impressionViewable');
						}
					});
				}
				if(f.length){for(var i=0;i<f.length;++i){api_fallback(f[i]);}}else{api_fallback(f);}
				f=function(){AdBridg.serve()}
			}
			return googletag.cmd.push(f);
		}
		while (AdBridg.cmd.length) { AdBridg.cmd.push(AdBridg.cmd.shift()); }
  };
	fireOrSaveJsFunctions(1, function() {
		(function() {
	      var adb = document.createElement("script");
	      adb.async = true;
	      adb.type = "text/javascript";
	      adb.src = '//prod.adspsp.com/adb.2418030m.min.js';
	      var node = document.getElementsByTagName('script')[0];
	      node.parentNode.insertBefore(adb, node);

	      // Return control to GPT if the AdBridg library fails to load.
	      adb.onerror = function() {
	        if (AdBridg.exists) { return; }
	        document.createElement('IMG').src = '//adspsp.com/pt/2418030/3/1/?e=0';
	        window.adbridgFallback();
	      }
	  })();
	});
</script>

<!-- Load DFP -->
<script type="text/javascript">
	var googletag = googletag || { };
	googletag.cmd = googletag.cmd || [ ];
	fireOrSaveJsFunctions(1,function(){
		(function() {
			var gads = document.createElement("script");
			gads.async = true;
			gads.type = "text/javascript";
			var useSSL = "https:" == document.location.protocol;
			gads.src = (useSSL ? "https:" : "http:") + "//www.googletagservices.com/tag/js/gpt.js";
			var node =document.getElementsByTagName("script")[0];
			node.parentNode.insertBefore(gads, node);
		})();
	});
</script>

<!--New header bidding-->
<script>
var amzn_win=window,amzn_c=5,amzn_x=0;while(amzn_x<amzn_c){amzn_win=amzn_win.parent;if(amzn_win.apstag)try{amzn_win.apstag.renderImp(document,"%%PATTERN:amzniid%%");amzn_x=amzn_c}catch(e){}amzn_x++};
</script> 

<script type="text/javascript">
	fireOrSaveGoogleAdFunctions(function() {
		AdBridg.cmd.push(function () {
			// ADBRIDG MIGRATION: this command to set AdSense is one of the few
			// GPT commands that should not be replaced with our library proxy.
			googletag.pubads().set("adsense_background_color", "FFFFFF");
		});
	});
</script>


<script type="text/javascript">
	var googleDegfaultAdVars = {"main":"'prostate'","k1":"'prostatecancer'","k2":"'cancer'","k3":"'health'","uniq":"'325694'","msiteID":"'zytigacdi'","msiteactive":"'True'","sponsoredPageNid":"''"};
	var googleAdSlotInfo = [];
	
	fireOrSaveGoogleAdFunctions(function(){
		AdBridg.cmd.push({
		  config: {
		    k1: googleDegfaultAdVars.k1 || "",
		    k2: googleDegfaultAdVars.k2 || ""
		  }
		});	
	});
	
</script>

<!-- End of old ads area -->
<script type='text/javascript'>
//Page level targeting setup
var adRPV = Math.floor(Math.random()*100)+1;
adRPV = adRPV.toString();

fireOrSaveGoogleAdFunctions(function(){
// ADBRIDG MIGRATION: the `cmd` function needs to run through AdBridg, but the
// setTargeting methods should stay native to GPT.
AdBridg.cmd.push(function() {
	googletag.pubads().setTargeting('rpv', adRPV);
	//We need to add a new key for 'url'
    googletag.pubads().setTargeting('url', encodeURI(location.pathname));

    //Set default targeting first
            if (typeof googleDegfaultAdVars !== "undefined") {
            for (var k in googleDegfaultAdVars) {
                if (k == "sub" || googleDegfaultAdVars[k].toString().indexOf(",") > -1) {
                    var finalOutput = googleDegfaultAdVars[k].split(',');
                    //Remove the single qoute
                    for (var i in finalOutput) {
                        if (finalOutput[i].trim().toString().indexOf("'") == 0) {
                            finalOutput[i] = finalOutput[i].trim().slice(1, -1);
                        } else {
    						finalOutput[i] = finalOutput[i].trim();
                        }
                    }
                } else {
                    if (googleDegfaultAdVars[k].toString().indexOf("'") == 0) {
                        //if it got single qoute inside, we remove it
                        var finalOutput = googleDegfaultAdVars[k].slice(1, -1);
                    } else {
                        var finalOutput = googleDegfaultAdVars[k];
                    }
                }
                googletag.pubads().setTargeting(k, finalOutput);
            }
        }
    	//googletag.pubads().enableAsyncRendering(); // enable async loading
	// Disable initial load, we will use refresh() to fetch ads.
	// Calling this function means that display() calls just
	// register the slot as ready, but do not fetch ads for it.
	// googletag.pubads().disableInitialLoad();
 //  	googletag.pubads().enableSingleRequest();
    // googletag.pubads().enableLazyLoad({
    //     fetchMarginPercent: 50,  // Fetch slots within 5 viewports.
    //     renderMarginPercent: 30,  // Render slots within 2 viewports.
    //     mobileScaling: 2.0  // Double the above values on mobile.
    // });
	// googletag.enableServices();
    // ADBRIDG MIGRATION: by default, we enable single request, disable initial
    // load, and async rendering is enabled by default (GPT no longer supports
    // synchronous rendering as of 2019-01-21.)
    // All we need to do now is tell AdBridg to begin serving the ads.
    // AdBridg.serve();
    // console.log("serve happened in page level");

});
});
</script>
<script>
// check viewport for resize events and reload ads (1000ms delay)
var resizeTimer;
var width = window.innerWidth;

function resizer() {
	//Check to see if the width is changed 
	var newWidth = window.innerWidth;
	if (width != newWidth) {
		// check if we've crossed a break point (only need to refresh if crossing the 1000px break point)
		if (width >= 1000 && newWidth < 1000) {
			
							// DECREASE IN WIDTH
				fireOrSaveGoogleAdFunctions(function() {
					AdBridg.cmd.push(function () {
						if (typeof window.DLB1 !== "undefined") {
							AdBridg.refresh([window.DLB1]);
						}
					});
				});
			
			// send resize+refresh event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / Shrink / Ad refresh', eventLabel: 'Resize / Shrink / Ad refresh'});});
			
		} else if (width < 1000 && newWidth >= 1000) {
			
			// INCREASE IN WIDTH
			// 
							if(typeof window.DLB1 !== "undefined"){
					AdBridg.refresh([window.DLB1]);	
				}
						
			// send resize+refresh event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / Grow / Ad refresh', eventLabel: 'Resize / Grow / Ad refresh'});});
			
		} else {
			// send resize event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / No ad refresh', eventLabel: 'Resize / No ad refresh'});});
		}
	}

	width = newWidth;
}

window.addEventListener("resize", function(){ 
	clearTimeout(resizeTimer);
	resizeTimer = setTimeout(resizer, 1000);
});

</script>

<!--New header bidding-->
<script>
		!function(a9,a,p,s,t,A,g){if(a[a9])return;function q(c,r){a[a9]._Q.push([c,r])}a[a9]={init:function(){q("i",arguments)},fetchBids:function(){q("f",arguments)},setDisplayBids:function(){},_Q:[]};A=p.createElement(s);A.async=!0;A.src=t;g=p.getElementsByTagName(s)[0];g.parentNode.insertBefore(A,g)}("apstag",window,document,"script","//c.amazon-adsystem.com/aax2/apstag.js");


		var initParams = {
			pubID: '3083',
			adServer: 'googletag'
		};


		fireOrSaveJsFunctions(1,function(){

			if (passEEACheck||(isEEA&&glob_mntcookie)) {
				__cmp('getConsentData', null, function(vendorConsentData, success) {
					
					initParams.gdpr = { enabled: true, consent: vendorConsentData.metadata };
					apstag.init(initParams);
				});
			} else {
				apstag.init(initParams);
			}

	 })

</script>

	


	<script type="text/javascript">
	this.top.location!==this.location&&(this.top.location=this.location);
	</script>
	<style>.async-hide { opacity: 0 !important} </style>
<script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date;
h.end=i=function(){s.className=s.className.replace(RegExp(' ?'+y),'')};
(a[n]=a[n]||[]).hide=h;setTimeout(function(){i();h.end=null},c);h.timeout=c;
})(window,document.documentElement,'async-hide','dataLayer',4000,
{'GTM-W59HFNJ':true});</script>

	<script type="text/javascript">

			<!-- GA Universal Code 2014-08 (obfuscated) -->

			eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('5(-1,2(){(2(i,s,o,g,r,a,m){i[\'c\']=r;i[r]=i[r]||2(){(i[r].q=i[r].q||[]).e(d)},i[r].l=1*j h();a=s.b(o),m=s.6(o)[0];a.7=1;a.8=g;m.9.k(a,m)})(y,A,\'z\',\'//x.n-3.t/3.u\',\'4\')});5(-1,2(){4(\'v\',\'p-w-1\',\'f\')});',37,37,'||function|analytics|ga|fireOrSaveJsFunctions|getElementsByTagName|async|src|parentNode||createElement|GoogleAnalyticsObject|arguments|push|auto||Date||new|insertBefore|||google||UA||||com|js|create|849615|www|window|script|document'.split('|')))


	</script>
		<script type="text/javascript">
	/*
	CSS Browser Selector v0.4.0 (Nov 02, 2010)
	Rafael Lima (http://rafael.adm.br)
	http://rafael.adm.br/css_browser_selector
	License: http://creativecommons.org/licenses/by/2.5/
	Contributors: http://rafael.adm.br/css_browser_selector#contributors
	*/
	function css_browser_selector(u){var ua=u.toLowerCase(),is=function(t){return ua.indexOf(t)>-1},g='gecko',w='webkit',s='safari',o='opera',m='mobile',h=document.documentElement,b=[(!(/opera|webtv/i.test(ua))&&/msie\s(\d)/.test(ua))?('ie ie'+RegExp.$1):is('firefox/2')?g+' ff2':is('firefox/3.5')?g+' ff3 ff3_5':is('firefox/3.6')?g+' ff3 ff3_6':is('firefox/3')?g+' ff3':is('gecko/')?g:is('opera')?o+(/version\/(\d+)/.test(ua)?' '+o+RegExp.$1:(/opera(\s|\/)(\d+)/.test(ua)?' '+o+RegExp.$2:'')):is('konqueror')?'konqueror':is('blackberry')?m+' blackberry':is('android')?m+' android':is('chrome')?w+' chrome':is('iron')?w+' iron':is('applewebkit/')?w+' '+s+(/version\/(\d+)/.test(ua)?' '+s+RegExp.$1:''):is('mozilla/')?g:'',is('j2me')?m+' j2me':is('iphone')?m+' iphone':is('ipod')?m+' ipod':is('ipad')?m+' ipad':is('mac')?'mac':is('darwin')?'mac':is('webtv')?'webtv':is('win')?'win'+(is('windows nt 6.0')?' vista':''):is('freebsd')?'freebsd':(is('x11')||is('linux'))?'linux':'','js']; c = b.join(' '); h.className += ' '+c; return c;}; css_browser_selector(navigator.userAgent);
	</script>
	<script type="text/javascript">
var viewportWidth = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);
var viewportHeight = Math.max(document.documentElement.clientHeight, window.innerHeight || 0);

	switch (true) {
		case viewportWidth > 1360:
			var viewportBreakpoint = 'Desktop - XL';
			break;
		case viewportWidth > 1200:
			var viewportBreakpoint = 'Desktop - L';
			break;
		case viewportWidth > 1000:
			var viewportBreakpoint = 'Desktop - M';
			break;
		default:
			var viewportBreakpoint = 'Desktop - S';
	}
	
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension20', viewportBreakpoint);});

var existUserId=false;
var vanillaAjax=function(url,httpMethod,data,headerJsonString){

	var request = new XMLHttpRequest();


	request.open(httpMethod, url, true);


	//set header if exist
	try{
		var headerObj=JSON.parse(headerJsonString);

		for (var headerName in headerObj) {

			//optional check for properties from prototype chain
			if (headerObj.hasOwnProperty(headerName)) {
				//no a property from prototype chain

				var headerValue = headerObj[headerName];
				request.setRequestHeader(headerName,headerValue);

			}
		}

	}catch(e){
		console.log("Set datadog api header failed");
		//don't set header if something wrong;
	}




	request.onload = function() {

		if (request.status >= 200 && request.status < 400) {
			// Success!
			var resp = request.responseText;

		} else {
			// We reached our target server, but it returned an error

		}
	};

	request.onerror = function() {
		// There was a connection error of some sort
	};

	request.send(data);

};



function getUrlVars(targetField) {
	var vars = {};
	var parts = window.location.href.replace(/[?&]+([^=&]+)=([^&]*)/gi,
	function(m,key,value) {
		vars[key] = value;
	});

	if(typeof vars[targetField] !== "undefined"){

		return vars[targetField];

	}else{

		return "";
 	}

}


fireOrSaveJsFunctions(0,function() {ga('set', 'dimension35', getUrlVars("tc"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension36', getUrlVars("subid"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension37', getUrlVars("subid2"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension38', getUrlVars("apsid"));});


//set dimension34 value if exist

if(existUserId){

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension34', existUserId);});

}else if(getUrlVars("apid")){

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension34', getUrlVars("apid"));});

	vanillaAjax("/account/message-session-setter.php","POST","activation_platform_user_id="+getUrlVars("apid"),"{\"Content-type\":\"application/x-www-form-urlencoded\"}");

}

//will be called from newsletter register.
function setUserId(userId){

ga('set', 'dimension34', ""+userId);

}

fireOrSaveJsFunctions(0,function() {ga('set', 'dimension40', 'Victor Nguyen, PharmD, MS');});
		

fireOrSaveJsFunctions(0,function() {ga('set', {
'dimension1': "no",
'dimension2': "drugs_tabbed",
'dimension3': "Prostate / Prostate Cancer",
'dimension5': "month",
'dimension6': "desktop",
'dimension12': "2019-08-15",
'dimension17': "7721",
'dimension21': "2",
'dimension23': "Lindsay Slowiczek, PharmD",
'dimension27': "1",
'dimension28': "prostatecancer",
'dimension29': "cancer"
});});

if (window.devicePixelRatio) {
	var pixelRatio = (window.devicePixelRatio >= 1.5) ? "HiDPI" : "1X";
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension7', pixelRatio);});
}

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension10', viewportWidth);});
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension11', viewportHeight);});
	
	var MNT_ga_paramKey = (document.location.search.indexOf('?') > -1 ? '&' : '?');
	var MNT_ga_url_msId_fragment = MNT_ga_paramKey + 'gaPage=[zytigacdi]';  
	var MNT_ga_url_msId = document.location.pathname + document.location.search + MNT_ga_url_msId_fragment;
	
		fireOrSaveJsFunctions(0,function() {ga('set', 'page', MNT_ga_url_msId);});
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension16', 'zytigacdi');});fireOrSaveJsFunctions(0,function() {ga('require', 'GTM-W59HFNJ');});
fireOrSaveJsFunctions(0,function() {ga('send', 'pageview');});

setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 030','325694')});",30000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 050','325694')});",50000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 070','325694')});",70000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 090','325694')});",90000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 110','325694')});",110000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 130','325694')});",130000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 150','325694')});",150000)
</script>
<script>
	fireOrSaveJsFunctions(1,function() {

		var _qevents = _qevents || [];

		(function() {
			var elem = document.createElement('script');
			//elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js";
			elem.src = "https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/quant.js";
			elem.async = true;
			elem.type = "text/javascript";
			var scpt = document.getElementsByTagName('script')[0];
			scpt.parentNode.insertBefore(elem, scpt);
		})();

		_qevents.push({
			qacct:"p-v03RmX3GES6RT"
		});
	});


</script>

<script>
	fireOrSaveJsFunctions(1,function() {

		window._comscore = window._comscore || [];
		window._comscore.push({ c1: "2", c2: "19983957" });
		(function() {
			var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true;
			//s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
			s.src = "https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/beacon.js";
			el.parentNode.insertBefore(s, el);
		})();

	})

</script>
<noscript>
  <img class="no_js" src="https://sb.scorecardresearch.com/p?c1=2&c2=19983957&cv=2.0&cj=1" />
</noscript>

<script>


	fireOrSaveJsFunctions(1,function() {

		!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
			n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
			n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
			t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
			document,'script','https://connect.facebook.net/en_US/fbevents.js');

		fbq('init', '1039134266174910');
		fbq('track', "PageView");

		fbq('track', 'ViewContent');

	});


</script>

<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=1039134266174910&ev=PageView&noscript=1"
/></noscript>

<!-- Source: /controltag?confid=qqeynsltk&site=medical%20news%20today&edit=1 -->
<script class="kxct" data-id="qqeynsltk" data-timing="async" data-version="1.9" type="text/javascript">
	fireOrSaveJsFunctions(1,function() {
		window.Krux || ((Krux = function () {
			Krux.q.push(arguments)
		}).q = []);
		(function () {
			var k = document.createElement('script');
			k.type = 'text/javascript';
			k.async = true;
			var m, src = (m = location.href.match(/\bkxsrc=([^&]+)/)) && decodeURIComponent(m[1]);
			k.src = /^https?:\/\/([a-z0-9_\-\.]+\.)?krxd\.net(:\d{1,5})?\//i.test(src) ? src : src === "disable" ? "" :
			(location.protocol === "https:" ? "https:" : "http:") + "//cdn.krxd.net/controltag?confid=qqeynsltk";
			var s = document.getElementsByTagName('script')[0];
			s.parentNode.insertBefore(k, s);
		}());
	});
</script>


<!-- Hotjar Tracking Code for https://www.medicalnewstoday.com/ -->
<script>
	(function(h,o,t,j,a,r){
		h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
		h._hjSettings={hjid:1295463,hjsv:6};
		a=o.getElementsByTagName('head')[0];
		r=o.createElement('script');r.async=1;
		r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
		a.appendChild(r);
	})(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
</script>
<script type="text/javascript"> window.jstag=function(){function t(t){return function(){return t.apply(this,arguments),this}}function n(){var n=["ready"].concat(c.call(arguments));return t(function(){n.push(c.call(arguments)),this._q.push(n)})}var i={_q:[],_c:{},ts:(new Date).getTime(),ver:"2.0.0"},c=Array.prototype.slice;return i.init=function(t){return i._c=t,t.synchronous||i.loadtagmgr(t),this},i.loadtagmgr=function(t){var n=document.createElement("script");n.type="text/javascript",n.async=!0,n.src=t.url+"/api/tag/"+t.cid+"/lio.js";var i=document.getElementsByTagName("script")[0];i.parentNode.insertBefore(n,i)},i.ready=n(),i.send=n("send"),i.mock=n("mock"),i.identify=n("identify"),i.pageView=n("pageView"),i.bind=t(function(t){i._q.push([t,c.call(arguments,1)])}),i.block=t(function(){i._c.blockload=!0}),i.unblock=t(function(){i._c.blockload=!1}),i}(),window.jstag.init({cid:"107d418c4b7bb3debf57a3af0ce16190", url:"//c.lytics.io", min:true, loadid:false}); </script>

<!-- Facebook Pixel Code -->
<script>

	fireOrSaveJsFunctions(1,function() {

		!function (f, b, e, v, n, t, s) {
			if (f.fbq)return;
			n = f.fbq = function () {
				n.callMethod ?
					n.callMethod.apply(n, arguments) : n.queue.push(arguments)
			};
			if (!f._fbq)f._fbq = n;
			n.push = n;
			n.loaded = !0;
			n.version = '2.0';
			n.queue = [];
			t = b.createElement(e);
			t.async = !0;
			t.src = v;
			s = b.getElementsByTagName(e)[0];
			s.parentNode.insertBefore(t, s)
		}(window,
			document, 'script', 'https://connect.facebook.net/en_US/fbevents.js');

		fbq('init', '1039134266174910');
		fbq('track', "PageView");
	});
</script>

<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=1039134266174910&ev=PageView&noscript=1"
/></noscript>



<!--Moat content code-->
<script>

	fireOrSaveJsFunctions(1,function(){

		(function(){function t(){for(var a=[8],e=1;2>=e;e++)a.push(8+e),a.push(8-e);a=a[Math.floor(Math.random()*a.length)];return{b:a,a:0==Math.floor(Math.random()*a)}}function k(a){var e=a=a.replace(":","");try{for(var b=0;100>b&&(a=decodeURIComponent(a),e!=a)&&!a.match(/^http(s)?\:/);b++)e=a}catch(c){}return a.replace(/(^\s+|\s+$)/g,"")}try{if(!location||!location.hostname||!location.pathname)return!1;var c=document.location.hostname.replace(/^www\./,""),u=function(){for(var a,b=document.getElementsByTagName("meta"),c,d=0,f=b.length;d<f;d++)if(c=b[d],"og:title"===c.getAttribute("property")){a=c.getAttribute("content");break}a||(a=document.title||"Untitled");return a}(),b={},b=function(a,b,c){a.l1=b;a.l2=c;a.l3="__page__";a.l4="-";return a}(b,c,u),l=(new Date).getTime(),m=Math.floor(Math.random()*Math.pow(10,12)),d,f;f=t();f.a?d=f.b:d=0;b.zmoatab_cm=d;b.t=l;b.de=m;b.zMoatAB_SNPT=!0;var g;d?g=d:g=1;var n;n=f?f.a?!0:!1:!0;var c=[],p=[k(b.l1),k(b.l2),k(b.l3),k(b.l4)].join(":"),v="https://wve3oiypgri4-a.akamaihd.net/z.gif?e=17&d="+
			encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&mp=1&ac=1&pl=1&bq=10&vc=2&cs=0",w="https://px.moatads.com/pixel.gif?e=17&d="+encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&mp=0&ac=1&pl=1&bq=10&ad_type=img&vc=2&cs=0",x="https://px.moatads.com/pixel.gif?e=17&d="+encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&ku=1&ac=1&pl=1&bq=10&ad_type=img&vc=2&cs=0";n&&((new Image).src=v,(new Image).src=w);for(var q in b)c.push(q+"="+encodeURIComponent(b[q]));
			var c=c.join("&"),c=c+"&vc=2",h=document.createElement("script");h.type="text/javascript";h.async=!0;n&&(h.onerror=function(){(new Image).src=x});var r=document.getElementsByTagName("script")[0];r.parentNode.insertBefore(h,r);h.src="https://z.moatads.com/healthlinecontent451781663455/moatcontent.js#"+c}catch(a){try{var y="//pixel.moatads.com/pixel.gif?e=24&d=data%3Adata%3Adata%3Adata&i=MOATCONTENTABSNIPPET1&vc=2&ac=1&k="+encodeURIComponent(a)+"&j="+encodeURIComponent(document.referrer)+"&cs="+(new Date).getTime();
			(new Image).src=y}catch(e){}}})();


	});

</script>
</head>
<body id="drugs" class="article v2 tabbed lang_en">
<div itemscope="" itemtype="http://schema.org/NewsArticle">








<noscript>
<div class="header_message enable_js error">
<p>For full functionality, it is necessary to enable JavaScript. Here are <a href="http://www.enable-javascript.com" rel="noopener noreferrer" target="_blank">instructions how to enable JavaScript</a> in your web browser.</p>
</div>


<div class="fullscreen_outer">
	<div class="fullscreen_inner">
		<h5>Welcome to Medical News Today</h5>
		<p>
			Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a <a href="https://www.medicalnewstoday.com/privacy-policy#vendors" target="_blank">current list</a>) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.</p>
		<p>
			Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.
		</p>
		<p>
			By clicking “accept” below, you acknowledge and grant your consent for these activities unless and until you withdraw your consent using our <a href="https://www.healthline.com/rights-request" rel="noopener noreferrer" target="_blank">rights request form</a>. Learn more in our <a href="https://www.medicalnewstoday.com/privacy-policy" target="_blank">Privacy Policy</a>.
		</p>
	</div>
</div>


</noscript>
<div id="header_message" class="new_menu">
<input type="hidden" id="is_usermobile" name="is_usermobile" value="0">





 
</div>

<div id="navigation" class="container default_menu new_menu">

	<div class="row">

		<nav role="navigation" class="main_nav">
		
			<ul class="main_nav left"> 	
				<li class="menu_topics">
					<a href="#"></a>
		
					
<div class="menu_panel fullscreen_outer topics">
  <div class="menu_panel fullscreen_inner">
    <div class="row">
					
					
					<div class="topics">
												
							<div class="menu_topic_container">
							
								<ul class="topic_headings">
									<li class="topic_headings_top"><span>Top categories</span>
										<ul class="topic_popular_list">
											<li><a href="/categories/blood">Blood / Hematology</a></li>
<li><a href="/categories/bones">Bones / Orthopedics</a></li>
<li><a href="/categories/breast_cancer">Breast Cancer</a></li>
<li><a href="/categories/colorectal_cancer">Colorectal Cancer</a></li>
<li><a href="/categories/depression">Depression</a></li>
<li><a href="/categories/gastrointestinal">GastroIntestinal</a></li>
<li><a href="/categories/hypertension">Hypertension</a></li>
<li><a href="/categories/lymphoma">Lymphoma</a></li>
<li><a href="/categories/mens_health">Men's Health</a></li>
<li><a href="/categories/neurology">Neurology / Neuroscience</a></li>
<li><a href="/categories/nutrition-diet">Nutrition / Diet</a></li>
<li><a href="/categories/pain">Pain / Anesthetics</a></li>
<li><a href="/categories/prostate">Prostate / Prostate Cancer</a></li>
<li><a href="/categories/psoriasis">Psoriasis</a></li>
<li><a href="/categories/respiratory">Respiratory</a></li>
<li><a href="/categories/sexual_health">Sexual Health / STDs</a></li>
<li><a href="/categories/stroke">Stroke</a></li>
<li><a href="/categories/tuberculosis">Tuberculosis</a></li>
<li><a href="/categories/urology-nephrology">Urology / Nephrology</a></li>
<li><a href="/categories/womens_health">Women's Health</a></li>
										</ul> 	
									</li>
																											
									<li class="topic_headings_all"><span>All categories</span>
										<ul class="topic_all_list">
											<li><a href="/categories#a">A - B</a></li>
											<li><a href="/categories#c">C - D</a></li>
											<li><a href="/categories#e">E - G</a></li>
											<li><a href="/categories#h">H - L</a></li>
											<li><a href="/categories#m">M - O</a></li>
											<li><a href="/categories#p">P - R</a></li>
											<li><a href="/categories#s">S - Z</a></li>
											<li><a href="/categories">All Topics</a></li>
										</ul>	
									</li>


								</ul> 									
							</div> 	
						
							<div class="menu_cta_container">
							
									<span>More</span>	
																		
									<ul class="topic_more_list">
										<li class="menu_newsletter_cta"><a href="#" class="new_reg_signup menu_item_link" data-signup-source="menu_item_link"><span class="icon_container"></span>Sign up for our newsletter</a></li>
										<li class="menu_discover_cta"><a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-menu-cta-2017.png" height="15" width ="34"/>Discover in-depth, condition specific articles written by our in-house team.</a></li>

									</ul> 	
	
							</div> 	
			
			
											
					</div> 	
					</div> 	
					</div> 	
											
											
											
					</div> 	
			  
				</li> 	

					<li class="menu_newsletter">

						<a href="#" data-signup-source="menu_newsletter_link" class="menu-newsletter-link  new_reg_signup"><div>Newsletter</div></a>

					</li> 	

			</ul>
				
			<div class="logo">
				<a href="/" accesskey="h" title="Medical News Today : Home">
					<img src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-2017-640-60.png" alt="MNT home">
					<p>MNT - Hourly Medical News Since 2003</p>
				</a>
			</div> 	
				
			<ul class="main_nav right"> 	

			<div id="search_area">


<div id="searchwrapper" class="">



<div class="search_trigger">

<form id="searchFormHeader" action="/search" >
<input type="text" id="header_search" placeholder="" class="searchbox" name="q" maxlength="150" autocomplete="off"/>
<button class="screen_only black float_right" id="header_search_button" type="submit" id="" title="Search MNT" value="">Search</button>
<button class="mobile_only blue float_right" id="header_search_button" type="submit" title="Search MNT" value="">Go</button>
<input type="hidden" name="p" value="1" />
</form>



</div>
	

</div>
</div>	
			


					<li class="menu_login">
						<a href="#" id="menu_login_link">
							<div>

							</div>
						</a>
					</li>
			</ul>
		</nav>	

	</div> 	

</div> 
<div id="navigation_scroll" class="container light  ">

<div class="row">

<nav id="subnavigation">

			<ul class="main_nav left"> 	
				<li class="menu_topics">
					<a href="#"></a>
		
					
<div class="menu_panel fullscreen_outer topics">
  <div class="menu_panel fullscreen_inner">
    <div class="row">
					
					
					<div class="topics">
												
							<div class="menu_topic_container">
							
								<ul class="topic_headings">
									<li class="topic_headings_top"><span>Top categories</span>
										<ul class="topic_popular_list">
											<li><a href="/categories/blood">Blood / Hematology</a></li>
<li><a href="/categories/bones">Bones / Orthopedics</a></li>
<li><a href="/categories/breast_cancer">Breast Cancer</a></li>
<li><a href="/categories/colorectal_cancer">Colorectal Cancer</a></li>
<li><a href="/categories/depression">Depression</a></li>
<li><a href="/categories/gastrointestinal">GastroIntestinal</a></li>
<li><a href="/categories/hypertension">Hypertension</a></li>
<li><a href="/categories/lymphoma">Lymphoma</a></li>
<li><a href="/categories/mens_health">Men's Health</a></li>
<li><a href="/categories/neurology">Neurology / Neuroscience</a></li>
<li><a href="/categories/nutrition-diet">Nutrition / Diet</a></li>
<li><a href="/categories/pain">Pain / Anesthetics</a></li>
<li><a href="/categories/prostate">Prostate / Prostate Cancer</a></li>
<li><a href="/categories/psoriasis">Psoriasis</a></li>
<li><a href="/categories/respiratory">Respiratory</a></li>
<li><a href="/categories/sexual_health">Sexual Health / STDs</a></li>
<li><a href="/categories/stroke">Stroke</a></li>
<li><a href="/categories/tuberculosis">Tuberculosis</a></li>
<li><a href="/categories/urology-nephrology">Urology / Nephrology</a></li>
<li><a href="/categories/womens_health">Women's Health</a></li>
										</ul> 	
									</li>
																											
									<li class="topic_headings_all"><span>All categories</span>
										<ul class="topic_all_list">
											<li><a href="/categories#a">A - B</a></li>
											<li><a href="/categories#c">C - D</a></li>
											<li><a href="/categories#e">E - G</a></li>
											<li><a href="/categories#h">H - L</a></li>
											<li><a href="/categories#m">M - O</a></li>
											<li><a href="/categories#p">P - R</a></li>
											<li><a href="/categories#s">S - Z</a></li>
											<li><a href="/categories">All Topics</a></li>
										</ul>	
									</li>

								</ul> 									
							</div> 	
						
							<div class="menu_cta_container">
							
									<span>More</span>	
																		
									<ul class="topic_more_list">

										<li class="menu_newsletter_cta"><a href="#" class="new_reg_signup menu_item_link" data-signup-source="menu_item_link"><span class="icon_container"></span>Sign up for our newsletter</a></li>
										<li class="menu_discover_cta"><a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-menu-cta-2017.png" height="15" width ="34"/>Discover in-depth, condition specific articles written by our in-house team.</a></li>

									</ul> 	
	
							</div> 	
			
			
											
					</div> 	
					</div> 	
					</div> 	
											
											
											
					</div> 	
			  
				</li> 

					<li class="menu_newsletter">

						<a href="#" data-signup-source="menu_newsletter_link" class="menu-newsletter-link  new_reg_signup"><div>Newsletter</div></a>

					</li> 
				
			</ul>
				
			<div class="logo">
				<a href="/" accesskey="h" title="Medical News Today : Home">
					<img src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-2017-640-60.png" alt="MNT home">
					<p>MNT - Hourly Medical News Since 2003</p>
				</a>
			</div> 	
				
			<ul class="main_nav right"> 	
				
					

			<div id="search_area">


<div id="searchwrapper" class="">



<div class="search_trigger">

<form id="searchFormHeader" action="/search" >
<input type="text" id="header_search" placeholder="" class="searchbox" name="q" maxlength="150" autocomplete="off"/>
<button class="screen_only black float_right" id="header_search_button" type="submit" id="" title="Search MNT" value="">Search</button>
<button class="mobile_only blue float_right" id="header_search_button" type="submit" title="Search MNT" value="">Go</button>
<input type="hidden" name="p" value="1" />
</form>



</div>
	

</div>
</div>	
			


					<li class="menu_login">
						<a href="#" id="menu_login_link">
							<div>

							</div>
						</a>

					</li>
			</ul>
		
		</nav>	

	</div> 	

</div> <div class="modal fade" id="picModal" tabindex="-1" role="dialog" style="z-index: 1040; padding-left:0;">
	<div class="modal-dialog" role="document">
		<div class="modal-content" style="">
			<div class="modal-header">
				<button type="button" class="close" data-dismiss="modal" aria-label="Close"></button>

			</div>
			<div class="modal-body" style="text-align: center;">

				<div id="picModal-loading-animation">

					<i class="fa fa-circle-o-notch fa-spin fa-3x fa-fw"></i>
					<span class="sr-only">Loading...</span>

				</div>


				<span class="helper" style="display: inline-block;height: 100%;vertical-align: middle;"></span> <img id="origin-img" src="">

			</div>

		</div>
	</div>
</div>


<div class="modal fade site_modal modal_gdpr" tabindex="-1" role="dialog" aria-hidden="true" id="gdprModal" data-backdrop="static" data-keyboard="false">
	<div class="modal-dialog" role="document">

		<div class="modal-content">

			<div class="modal-header">
			</div>

			<div class="modal-body container" onscroll="modalScroll()">
				<div class="fullscreen_outer article_header">
					<div class="fullscreen_inner">
						<h5>Please accept our privacy terms</h5>
						<p>
							We use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our <a href="https://www.medicalnewstoday.com/advertising" target="_blank">Advertising Policy</a> and <a href="https://www.medicalnewstoday.com/privacy-policy" target="_blank">Privacy Policy</a>. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States.
						</p>
					</div>
				</div>
			</div>
			<div class="modal-footer container gradient">
				<div class="article_header">
					<button class="primary" onclick="GDPRAccept()">ACCEPT AND CONTINUE TO SITE</button>
					<button class="secondary" onclick="confirmDeny()">Deny permission</button>
				</div>
			</div>

		</div>
		<div class="scroll_more hidden">
			<button class="primary" onclick="scrollAccept()">Scroll to Accept</button>
		</div>

	</div>
</div>



	<!--for new newsletter sign up proc-->
	<div class="modal fade registration_modal_form" tabindex="-1" role="dialog" aria-hidden="true" id="registrationModal">
		<div class="modal-dialog" role="document">
			<div class="modal-content modal_reg" id="registration_modal_form">
									<div class="modal-header screen_only">
						<h4 class="modal-title">Get the MNT newsletter</h4>
						<button type="button" class="close" data-dismiss="modal"></button>
					</div>
				


				<div class="modal-body" id="registration_start">

					<div class="iframe_scroll_container">

						<!--form migration start-->

						<form id="new-reg-form">
							<div class="form container_reg">
								<div class="form header_reg">

									<div class="form-group">
										<input type="email" name="formEmail" style="margin-bottom: 20px;" class="form-control newsletterFormEmail" id="inputEmail" placeholder="Enter email address" value="">
									</div>

									<!--error meesage place holder-->
									<div id="signFinishErrorHolder" class="errorHolder"></div>


									<div id="registration_modal_message" class="form-group">


										<!--while user finish the register process, something info need to tell user, but not error message-->
										<div id="newsletterRegisterInfo" class="message start">

										</div>


										<!--User will see the message everytime open the register modal-->
										<div id="newsletterTypeMessage" class="message start">

											<p>
												Enter your email address to subscribe to <span id="selectedCategoryText">our most top categories</span>
											</p>

											

<p>Your <a href="/privacy-policy" title="Privacy policy">privacy</a> is important to us.</p>

										</div>

									</div>

								</div>
							</div>

							<!--set by js-->
							<input type="hidden" id="newsletterCategories" name="newsletterCategories" value="">
							<input type="hidden" id="newsletterTypeMessageHTMLBackup" name="newsletterTypeMessageHTMLBackup" value="">

						</form>

						<!--form migration end-->

					</div>
				</div>


				<div class="modal-footer">
					<button type="button" id="email-start-signup-btn" class="btn btn-success btn-block">CONTINUE</button>

<!--					<button type="button" id="email-finish-signup-btn" class="btn btn-danger btn-block" data-dismiss="modal">OK</button>-->
				</div>				

			</div>



		</div><!-- /.modal-dialog -->
	</div><!-- /.modal -->



<div class="modal fade email-an-article-modal" tabindex="-1" role="dialog" aria-hidden="true" id="email-an-article-modal">
	<div class="modal-dialog" role="document">
		<div class="modal-content">
			<div class="modal-header">
				<h3 class="">Email an article</h3>
				<button type="button" class="close" data-dismiss="modal"></button>
			</div>
			<div class="modal-body">
				<p>You have chosen to share the following article:</p>
				<p><b id="email-an-article-title">How elderberries can help you fight the flu</b></p>
				<p>To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.<br>
					<b>Note:</b> Please don't include any URLs in your comments, as they will be removed upon submission.</p>
				<p>We do not store details you enter into this form. Please see our <a href="/privacy-policy" title="Read our Privacy Policy" target="_blank">privacy policy</a> for more information.</p>

				<form id="email-an-article-form">
					<fieldset class="form-container">
						<div>
							<label><em>*</em>Your Name (max. 30 chars)</label>
							<input id="fromName" type="text" name="fromName" maxlength="30" value="" required>
							<label for="fromName" generated="true" class="formError" style="display: none">The field 'Your Name' is required.</label>
						</div>
						<div>
							<label><em>*</em>Email Address</label>
							<input id="fromEmailAddress" class="formEmail" type="email" name="fromEmailAddress" maxlength="100" value="" required>
							<label for="fromEmailAddress" generated="true" class="formError" style="display: none">This is not a valid email address.</label>
						</div>
						<div>
							<label><em>*</em>Friend's Name (max. 30 chars)</label>
							<input id="toName" type="text" name="toName" maxlength="30" value="" required>
							<label for="toName" generated="true" class="formError" style="display: none">The field 'Friend's Name' is required.</label>
						</div>
						<div>
							<label><em>*</em>Friend's Email Address</label>
							<input id="toEmailAddress" type="email" name="toEmailAddress" maxlength="100" value="" required>
							<label for="toEmailAddress" generated="true" class="formError" style="display: none">The field 'Friend's Email Address' is required.</label>
						</div>

					</fieldset>


					<div id="email-an-article-reCAPTCHA" class="g-recaptcha" data-sitekey="6Le68KEUAAAAAOKVyWLvP5U0Dl2HT9dqR0J1hx7z"></div>




					<div class="buttonrow">
						<button type="submit" id="email_submit" class="btn-form form-submit secure">Send securely</button>
						<span class="form_secure_icon"></span>
					</div>

				</form>

				<div class="robots-nocontent">
					<div id="email-an-article-success" class="information"  style="display: none">
						<h2 class="message_box">Message sent successfully</h2>
						<p><b>The details of this article have been emailed on your behalf.</b></p>
						<p><a href="/" title="Click here to return to the MNT homepage">Click here</a> to return to the Medical News Today home page.</p>
					</div>
				</div>
			</div>
		</div>
	</div><!-- /.modal-dialog -->
</div>










<hr class="css_h1ksn" >






<div class="container"> 

<div class="row site_header"> 

<article  >

			<div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 article_header"> 		<!-- Leaderboard BANNER advert -->

<div id="dlb1_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb1_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB1',
			"slotContainer":'dlb1_container'		});
	</script>
	</div>
	<span class='bt-uid-tg' data-uid='5b84646203-160' style='display: none !important' data-style='width: 728px;height: 90px;background: rgba(255, 255, 255, 0.5);border: 2px solid #888;box-sizing: border-box;margin: 0 auto 0;'></span>

</div>






<!-- /header_ad code -->
<h1 itemprop="headline">Zytiga (abiraterone acetate)</h1>

</div> 	<div class="col-xs-12 col-sm-12 col-md-8 col-lg-8 main_content"> 	<div id="article_date">
			<span class="date_reviewed screen_only">Last reviewed		<time itemprop="lastReviewed" datetime="2019-06-23">
		Sun 23 June 2019		</time></span>
		
		<span class="date_reviewed mobile_only">Last reviewed		Sun 23 Jun 2019</span>
		
			</div>
		<div class="author_top">
	<span class='author_byline'>By Lindsay Slowiczek, PharmD</span>	</div>
				<div class="reviewer_top">
			<span class='reviewer_byline'>Reviewed by <a href='/reviewers' class='article_author' rel='author' title='MNT medical review team' >Victor Nguyen, PharmD, MS</a></span>			</div>
			<span class="clearfix"></span>

<div class="article_body">
	<div itemprop="articleBody">
	<div class="article_toc collapsed article_collapsed">
<a class="collapsed__click" href="#"><i class="collapsed__icon"></i>Table of contents</a><ol class="collapsed__tabs hide">
<li><a href="#generic">Generic</a></li>












<li><a href="#side-effects">Side effects</a></li>












<li><a href="#cost">Cost</a></li>












<li><a href="#dosage">Dosage</a></li>












<li><a href="#uses">Uses</a></li>












<li><a href="#alternatives">Alternatives</a></li>












<li><a href="#zytiga-vs-xtandi">Zytiga vs. Xtandi</a></li>












<li><a href="#zytiga-vs-other-drugs">Zytiga vs. other drugs</a></li>












<li><a href="#-zytiga-and-prednisone"> Zytiga and prednisone</a></li>












<li><a href="#-use-with-other-drugs"> Use with other drugs</a></li>












<li><a href="#zytiga-and-alcohol">Zytiga and alcohol</a></li>












<li><a href="#interactions">Interactions</a></li>












<li><a href="#how-to-take">How to take</a></li>












<li><a href="#how-it-works">How it works</a></li>












<li><a href="#pregnancy">Pregnancy</a></li>












<li><a href="#breastfeeding">Breastfeeding</a></li>












<li><a href="#faqs">FAQs</a></li>












<li><a href="#precautions">Precautions</a></li>












<li><a href="#overdose">Overdose</a></li>












<li><a href="#expiration">Expiration</a></li>












<li><a href="#professional-information">Professional information</a></li>












</ol>
</div>












<h2>What is Zytiga?</h2>












<p>Zytiga is a brand-name prescription medication. It's used to treat two types of prostate cancer:</p>












<ul>
<li>metastatic castration-resistant <a href="/articles/150086.php" title="Prostate cancer in detail" class="keywords">prostate cancer</a> (CRPC)</li>












<li>metastatic high-risk castration-sensitive prostate cancer (CSPC)</li>












</ul>
<p>Metastatic means the <a href="/info/cancer-oncology/" title="What is Cancer?" class="keywords">cancer</a> has spread to other parts of the body. Both of these cancers are considered advanced.</p>












<p>The word "castration" refers to the lowering of <a href="/articles/276013.php" title="Why do we need testosterone?" class="keywords">testosterone</a> levels. Testosterone usually plays a role in stimulating prostate cancer growth. Prostate cancer is considered castration-resistant if the cancer continues to grow or spread even with therapy or surgery to lower testosterone levels.</p>












<p>High-risk castration-sensitive cancer still responds to lowered testosterone levels but requires more aggressive treatment.</p>












<p>Zytiga contains the drug abiraterone acetate. It's a type of medication used in hormone therapy, which is a treatment that lowers the level of male hormones in the body. Reduced levels of male hormones, such as testosterone, help slow or stop the growth of prostate cancer cells.</p>












<p>Zytiga comes as an oral tablet that you take once a day. You'll take Zytiga with a corticosteroid (prednisone) to reduce the risk of certain side effects. In some cases, you'll take Zytiga and prednisone with a different type of hormone therapy to further lower testosterone levels.</p>












<h3>Effectiveness</h3>












<p>In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513" target="_blank" rel="noopener">clinical studies</a> of men with metastatic CRPC, taking Zytiga with prednisone in addition to standard hormone therapy prolonged life by about 4.5 months. For men with CSPC, drug therapy that included Zytiga lowered the risk of death by 34% over 52 months.</p>












<p><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1702900" target="_blank" rel="noopener">Another study</a> looked at men with either metastatic CRPC or CSPC who were starting hormone therapy for the first time. Those who took Zytiga had a three-year survival rate of 83%. This means that they lived for three years after they started taking the drug. Those who received standard therapy had a three-year survival rate of 76%.</p>












<p>Also in this study, Zytiga lowered the risk of death within three years of starting treatment by 37%. This was compared to standard therapy.</p>












<h3>FDA approval</h3>












<p>The Food and Drug Administration (FDA) approved Zytiga for metastatic CRPC in 2011.</p>












<p>The FDA approved Zytiga for CSPC in 2018.</p>












 <span class="anchor" id="generic"></span>
<h2>Zytiga generic</h2>












<p>Zytiga is a brand-name medication that contains abiraterone acetate. Zytiga comes as a 250-mg tablet and a 500-mg tablet.</p>












<p>A generic version of the 250-mg tablet of abiraterone acetate is available. The 500-mg tablet doesn't have a generic version.</p>












 <span class="anchor" id="side-effects"></span>
<h2>Zytiga side effects</h2>












<p>Zytiga can cause mild or serious side effects. The following list contains some of the key side effects that you may have while taking Zytiga. This list does not include all possible side effects.</p>












<p>For more information on the possible side effects of Zytiga, talk with your doctor or pharmacist. They can give you tips on how to deal with any side effects that may be bothersome.</p>












<h3>More common side effects</h3>












<p>The more common side effects of Zytiga include:</p>












<ul>
<li>joint pain, swelling, or stiffness</li>












<li>cough</li>












<li><a href="/articles/158634.php" title="What you should know about diarrhea" class="keywords">diarrhea</a></li>












<li>
<a href="/articles/159111.php" title="Everything you need to know about edema" class="keywords">edema</a> (swelling, typically in your hands, legs, and feet)</li>












<li><a href="/articles/73936.php" title="What is causing this headache?" class="keywords">headache</a></li>












<li>
<a href="/articles/248002.php" title="Fatigue: Why am I so tired and what can I do about it?" class="keywords">fatigue</a> (lack of energy)</li>












<li>flushing (warmth and redness in your skin)</li>












<li>nausea</li>












<li>vomiting</li>












<li>upper respiratory infection (sinus infection or common cold)</li>












</ul>
<p>Most of these side effects may go away within a few days or a couple of weeks. If they're more severe or don't go away, talk with your doctor or pharmacist.</p>












<h3>Serious side effects</h3>












<p>Serious side effects of Zytiga can vary in how often they occur.</p>












<p><strong>More common serious side effects</strong></p>












<p>Some common side effects that could result in serious health issues for some people include:</p>












<ul>
<li>
<a href="/articles/158800.php" title="Everything you need to know about anemia" class="keywords">Anemia</a> (low level of red blood cells)</li>












<li>Hypertension (<a href="/articles/159283.php" title="What to know about high blood pressure" class="keywords">high blood pressure</a>)</li>












<li>Electrolyte disorders (such as low <a href="/articles/287212.php" title="Everything you need to know about potassium" class="keywords">potassium</a> levels)</li>












<li>High <a href="/articles/9152.php" title="What causes high cholesterol?" class="keywords">cholesterol</a> levels</li>












<li>High triglyceride levels</li>












<li>High blood sugar levels</li>












<li>Decrease in liver function (your liver isn't working properly)</li>












<li>
<a href="/articles/189953.php" title="What to know about urinary tract infections" class="keywords">Urinary tract infections</a> (UTIs). Symptoms can include:</li>












<ul>
<li>burning feeling when you urinate</li>












<li>urinating more often than usual but not passing much urine</li>












<li>suddenly needing to urinate</li>












</ul>
<li>Kidney problems. Symptoms can include:</li>












<ul>
<li>UTIs (see UTI symptoms above)</li>












<li>having to urinate more often than usual</li>












<li>needing to urinate often at night</li>












<li>blood in urine</li>












</ul>
</ul>
<p>Your doctor will monitor you for these side effects at regularly scheduled office visits. If you have serious side effects that can't be controlled, your doctor may lower your Zytiga dose or have you stop treatment.</p>












<p><strong>Rare serious side effects</strong></p>












<p>These serious side effects from Zytiga aren't common, but they can occur. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>












<p>Serious side effects and their symptoms can include the following:</p>












<ul>
<li>Serious allergic reaction. Symptoms can include:</li>












<ul>
<li>trouble breathing</li>












<li>swelling of your tongue, mouth, or throat</li>












<li>
<a href="/articles/216095.php" title="Everything you need to know about angioedema" class="keywords">angioedema</a> (swelling under your skin, typically in your eyelids, lips, hands, or feet)</li>












</ul>
<li>Liver damage and liver failure. Symptoms can include:</li>












<ul>
<li>
<a href="/articles/165749.php" title="Everything you need to know about jaundice" class="keywords">jaundice</a> (yellowing of your skin or eyes)</li>












<li>dark urine</li>












<li>loss of appetite</li>












<li>itchy skin</li>












<li>stomach pain</li>












<li>fatigue (lack of energy)</li>












<li>severe nausea and vomiting</li>












</ul>
<li>Cardiac disorders, including abnormal heart rhythm and cardiac arrest (your heart stops beating). Symptoms can include:</li>












<ul>
<li>chest pain</li>












<li>feeling like your heart is skipping a beat</li>












<li>feeling like your heart is beating too fast or too slow</li>












<li>shortness of breath</li>












<li><a href="/info/anxiety/" title="What is Anxiety?" class="keywords">anxiety</a></li>












<li>dizziness</li>












<li>fainting</li>












</ul>
<li>Adrenal problems (especially if you stop taking prednisone, are under <a href="/articles/145855.php" title="Why stress happens and how to manage it" class="keywords">stress</a>, or get an infection). Symptoms can include:</li>












<ul>
<li>long-lasting fatigue (lack of energy)</li>












<li>loss of appetite</li>












<li>weight loss</li>












<li>muscle weakness</li>












<li>stomach pain</li>












</ul>
</ul>
<h3>Side effect details</h3>












<p>You may wonder how often certain side effects occur with this drug, or whether certain side effects pertain to it. Here's some detail on some of the side effects this drug may or may not cause.</p>












<p><strong>Liver damage</strong></p>












<p>Liver damage, severe liver toxicity (when harmful levels of the drug build up in your liver), and liver failure were reported as side effects in <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S5.3" target="_blank" rel="noopener">clinical studies</a> of Zytiga.</p>












<p>Symptoms of liver problems include jaundice (yellowing of your skin or eyes), urine that's darker than normal, stomach pain, nausea, and vomiting. Liver damage typically occurs during the first three months after starting Zytiga.</p>












<p>Six percent of people who took Zytiga in <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513" target="_blank" rel="noopener">clinical trials</a> had serious liver damage, based on liver function tests. The test results showed much higher than normal levels of the proteins alanine transaminase (ALT) and aspartate aminotransferase (AST), which the liver releases when it's damaged.</p>












<p>In fact, about 1% of people who took Zytiga in <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S5.3" target="_blank" rel="noopener">clinical studies</a> stopped taking the drug because of liver damage.</p>












<p>Your doctor will test your liver function before you start taking Zytiga and during your treatment. They'll test levels of ALT, AST, and bilirubin (yellowish pigment that your liver processes). If these levels are too high, you may need to take a lower dose of Zytiga or stop treatment.</p>












<p>If you have moderate liver damage before you begin taking Zytiga, your doctor will start you on a lower dose of Zytiga. They'll also check your liver function more often. If you have severe liver damage, you shouldn't take Zytiga.</p>












<p><strong>Urinary tract infection</strong></p>












<p>In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S5.3" target="_blank" rel="noopener">clinical studies</a>, up to 12% of people who took Zytiga had a urinary tract infection (UTI). In about 2% of these cases, the UTI was considered urgent and required <a href="/articles/10278.php" title="What to know about antibiotics" class="keywords">antibiotics</a> given as an injection into your vein (intravenous).</p>












<p>Symptoms of a UTI include feeling a burning sensation when you urinate, having to urinate often, and feeling that you have to urinate right away. If you have these symptoms, tell your doctor. You may need an antibiotic to help prevent the infection from spreading.</p>












<p><strong>Kidney effects</strong></p>












<p>Some people in <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513" target="_blank" rel="noopener">clinical studies</a> of Zytiga had side effects involving their kidneys, including:</p>












<ul>
<li>urinary tract infections (UTIs)</li>












<li>having to urinate more often than usual</li>












<li>needing to urinate often at night</li>












<li>blood in urine</li>












</ul>
<p>Some of these kidney effects may be related to a UTI, but they may not. If you have any of these symptoms, talk with your doctor about possible treatment options.</p>












<p><strong>Weight loss </strong>(not a side effect)</p>












<p>Weight loss wasn't a side effect reported in <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S5.3" target="_blank" rel="noopener">clinical studies</a> of Zytiga.</p>












<p>But some people may lose weight because of some of the side effects of Zytiga, including diarrhea, nausea, vomiting, and <a href="/articles/163484.php" title="What to know about indigestion or dyspepsia" class="keywords">upset stomach</a>. These side effects may prevent these people from eating on a regular schedule. These side effects may also prevent their bodies from taking in enough nutrients.</p>












<p>Weight loss is commonly one of the first signs of cancer, according to the <a href="https://www.cancer.org/cancer/cancer-basics/signs-and-symptoms-of-cancer.html" target="_blank" rel="noopener">American Cancer Society</a>. During cancer treatment, people may lose weight for many reasons, including medication side effects, <a href="/kc/depression-causes-symptoms-treatments-8933" title="What is depression and what can I do about it?" class="keywords">depression</a>, and loss of appetite.</p>












<p>Also, unexplained weight loss and muscle loss, called cachexia, is often seen during late-stage cancer due to poor food intake or poor food absorption.</p>












<p>Lastly, weight loss can be a symptom of liver damage or liver failure, which has been reported as a side effect in Zytiga <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S5.3" target="_blank" rel="noopener">clinical studies</a>.</p>












<p>If you're concerned about your weight loss, talk with your doctor. They can help create a diet plan that provides all the <a href="/articles/195878.php" title="Vitamins: What are they and what do they do?" class="keywords">vitamins</a>, minerals, and <a href="/articles/245588.php" title="How many calories should I eat a day?" class="keywords">calories</a> you need. They can also refer you to a dietitian or nutritionist specially trained to help people with cancer.</p>












 <span class="anchor" id="cost"></span>
<!--[MMR]--><!--[END MMR]--><h2>Zytiga cost</h2>












<p>As with all medications, the cost of Zytiga can vary. To find current prices for Zytiga in your area, check out <a href="https://www.wellrx.com/" target="_blank" rel="noopener">WellRx.com</a>. The cost you find on WellRx.com is what you would pay without insurance. Your actual cost will depend on your insurance plan, your location, and the pharmacy you use.</p>












<h3>Financial and insurance assistance</h3>












<p>If you need financial support to pay for Zytiga, or if you need help understanding your insurance coverage, help is available.</p>












<p>Janssen Biotech, Inc., the manufacturer of Zytiga, offers a program called Janssen CarePath. For more information and to find out if you're eligible for support, call 877-227-3728 or visit the <a href="https://www.janssencarepath.com/patient/zytiga/patient-support" target="_blank" rel="noopener">program website</a>.</p>












 <span class="anchor" id="dosage"></span>
<h2>Zytiga dosage</h2>












<p>The Zytiga dosage your doctor prescribes will depend on several factors. These include:</p>












<ul>
<li>your liver function (how well your liver is working)</li>












<li>the medications you take to treat other conditions</li>












</ul>
<p>Typically, your doctor will start you on the usual dosage. Then they'll adjust it over time to reach the amount that's right for you. Your doctor will ultimately prescribe the smallest dosage that provides the desired effect.</p>












<p>The following information describes dosages that are commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to suit your needs.</p>












<h3>Drug forms and strengths</h3>












<p>Zytiga comes in two strengths: a 250-mg uncoated tablet and a 500-mg film-coated tablet.</p>












<h3>Dosage for metastatic castration-resistant prostate cancer</h3>












<p>The usual recommended dose for metastatic castration-resistant prostate cancer is 1,000 mg of Zytiga taken once a day. The dosage may be taken as two 500-mg tablets or four 250-mg tablets.</p>












<p>With your Zytiga dose, you will also take 5 mg of prednisone by mouth twice a day. (For more information, see "Zytiga and prednisone" below).</p>












<p>If you haven't had your testicles surgically removed, you'll take an additional medication to lower your hormone levels.</p>












<h3>Dosage for metastatic high-risk castration-sensitive prostate cancer</h3>












<p>The usual recommended dose for metastatic high-risk castration-sensitive prostate cancer is 1,000 mg of Zytiga taken once a day. This dosage may also be taken as two 500-mg tablets or four 250-mg tablets.</p>












<p>With your Zytiga dose, you will also take 5 mg of prednisone by mouth once a day. (For more information, see "Zytiga and prednisone" below).</p>












<p>If you haven't had your testicles surgically removed, you'll take an additional medication to lower your hormone levels.</p>












<h3>Dosage for liver disease</h3>












<p>If you have moderately severe liver disease, the recommended dosage is 250 mg of Zytiga taken once a day.</p>












<h3>What if I miss a dose?</h3>












<p>If you miss a dose of Zytiga or prednisone, take a dose the next day at the regular time. Don't take two doses at one time or in the same day. Taking more than one dose of Zytiga or prednisone can increase your risk for side effects.</p>












<p>If you miss more than one dose, call your doctor.</p>












<p>Using a reminder tool can help you remember to take Zytiga every day.</p>












<h3>Will I need to use this drug long term?</h3>












<p>It depends. Your doctor may want you to continue your Zytiga treatment on a long-term basis if the drug is effective (works well) and safe for you. They'll monitor any side effects and your cancer progress to decide if Zytiga is right for you.</p>












 <span class="anchor" id="uses"></span>
<!--[DLB]--><!-- Leaderboard BANNER advert -->

<div id="dlb2_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb2_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB2',
			"slotContainer":'dlb2_container'		});
	</script>
	</div>
	<span class='bt-uid-tg' data-uid='5b846471dd-160' style='display: none !important' ></span>

</div>






<!-- /header_ad code --><!--[END DLB]--><h2>Zytiga uses</h2>












<div id="onequarter-of-article"></div>
<p>The Food and Drug Administration (FDA) approves prescription drugs such as Zytiga to treat certain conditions. Zytiga may also be used off-label for other conditions. Off-label use is when a drug that's approved to treat one condition is used to treat a different condition.</p>












<h3>Zytiga for metastatic prostate cancer</h3>












<p>Zytiga is approved to treat two types of metastatic prostate cancer:</p>












<ul>
<li>metastatic castration-resistant prostate cancer (CRPC)</li>












<li>metastatic high-risk castration-sensitive prostate cancer (CSPC)</li>












</ul>
<p>Metastatic prostate cancer is cancer that has spread from the prostate to other areas in the body.</p>












<p>The word "castration" refers to the lowering of testosterone levels. Testosterone usually plays a role in stimulating prostate cancer growth. Prostate cancer is considered castration-resistant if the cancer continues to grow or spread even with therapy or surgery to lower testosterone levels.</p>












<p>High-risk castration-sensitive cancer still responds to lowered testosterone levels but requires more aggressive treatment.</p>












<p>For either type of cancer, Zytiga is used with prednisone, a corticosteroid that helps lessen certain side effects.</p>












<p>Zytiga is also taken with other hormone therapy called androgen deprivation therapy (ADT), which further reduces male hormone levels. Examples of ADT options include:</p>












<ul>
<li>leuprolide acetate (Eligard)</li>












<li>goserelin acetate (Zoladex)</li>












<li>histrelin acetate (Vantas)</li>












<li>degarelix (Firmagon)</li>












</ul>
<p>An alternative to ADT medication is bilateral orchiectomy (surgical removal of the testicles), which also lowers testosterone levels.</p>












<h3>Uses that are not approved</h3>












<p>Zytiga may be used off-label for other uses. Off-label use is when a drug that's approved for one purpose is used for another purpose.</p>












<p><strong>Nonmetastatic prostate cancer</strong></p>












<p>Zytiga isn't FDA-approved to treat nonmetastatic prostate cancer. But the <a href="https://www.auanet.org/guidelines/prostate-cancer-castration-resistant-(2013-amended-2018)" target="_blank" rel="noopener">American Urological Association</a> recommends Zytiga as an option for people if all of the following apply:</p>












<ul>
<li>They have nonmetastatic castration-resistant prostate cancer (CRPC).</li>












<li>Their risk of developing metastatic prostate cancer is high.</li>












<li>They don't want or can't take standard therapy.</li>












<li>They're unwilling to "watch and wait" under their doctor's supervision.</li>












</ul>
<p>In one <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1702900" target="_blank" rel="noopener">clinical study</a>, about half of the people who received Zytiga had nonmetastatic CRPC. In this group, the use of Zytiga with standard therapy didn't improve the rate of overall survival by a significant amount compared to standard therapy alone. But people with nonmetastatic prostate cancer did go longer without having a significant change in cancer growth or needing to change therapy.</p>












 <span class="anchor" id="alternatives"></span>
<h2>Alternatives to Zytiga</h2>












<p>There are other drugs available that can treat your condition. Some may be better suited for you than others. If you're interested in finding an alternative to Zytiga, talk with your doctor to learn more about other medications that may work well for you.</p>












<h3>Alternatives for prostate cancer</h3>












<p>Examples of other drugs that may be used to treat prostate cancer include:</p>












<ul>
<li>enzalutamide (Xtandi)</li>












<li>docetaxel (Taxotere)</li>












<li>sipuleucel-T (Provenge)</li>












<li>cabazitaxel (Jevtana)</li>












<li>
<a href="/articles/158513.php" title="What to know about radiation therapy?" class="keywords">radiotherapy</a> (such as Xofigo)</li>












</ul>
<span class="anchor" id="zytiga-vs-xtandi"></span>
<!--[MMR]--><!--[END MMR]--><h2>Zytiga vs. Xtandi</h2>












<p>You may wonder how Zytiga compares to other medications that are prescribed for similar uses. Here we look at how Zytiga and Xtandi are alike and different.</p>












<p>Zytiga contains the drug abiraterone acetate. Xtandi contains the drug enzalutamide.</p>












<p>Both drugs decrease the activity of male hormones but work in slightly different ways. Zytiga blocks the production of certain male hormones. Xtandi helps prevent male hormones from attaching to their receptors (proteins on prostate cancer cells). In both cases, the drugs help stop the spread of prostate cancer.</p>












<h3>Uses</h3>












<p>Zytiga and Xtandi are both used to treat castration-resistant prostate cancer (CRPC). Castration-resistant cancer continues to spread despite the use of drugs that lower male hormone levels.</p>












<p>Zytiga is specifically FDA-approved to treat metastatic CRPC. The Food and Drug Administration (FDA) has also approved Zytiga to treat metastatic high-risk castration-sensitive prostate cancer (CSPC). Metastatic prostate cancer has spread from the prostate to other areas in the body. CSPC still responds to hormone therapy.</p>












<p>Xtandi is FDA-approved for metastatic and nonmetastatic CRPC. Nonmetastatic prostate cancer has not spread to other parts of the body yet.</p>












<p>Both drugs are taken along with other hormone therapy or following surgery to remove your testicles. This helps further reduce the effects of androgens (male hormones such as testosterone) on cancer cells.</p>












<h3>Drug forms and administration</h3>












<p>Zytiga and Xtandi are both given as pills. You take them once a day.</p>












<p>Zytiga comes as a 250-mg tablet and a 500-mg tablet. The usual dosage is 1,000 mg once a day. You should take Zytiga without food (on an empty stomach). You take Zytiga along with prednisone, a corticosteroid that helps reduce certain side effects.</p>












<p>Xtandi comes as a 40-mg capsule. The usual dosage is 160 mg once a day. You can take it with or without food.</p>












<p>Your doctor may change your dose of Zytiga or Xtandi if you're taking other medications that affect the levels of Zytiga or Xtandi in your body. You may also need a lower dose of Zytiga if you have liver disease.</p>












<h3>Side effects and risks</h3>












<p>Zytiga and Xtandi work in slightly different ways, so they have some similar and some different side effects. Below are examples of these side effects.</p>












<p><strong>More common side effects</strong></p>












<p>These lists contain examples of more common side effects that can occur with Zytiga, Xtandi, or with both drugs (when taken individually).</p>












<ul>
<li>
<strong>Can occur with Zytiga</strong>:</li>












<ul>
<li>cough</li>












</ul>
<li>
<strong>Can occur with Xtandi</strong>:</li>












<ul>
<li>weakness</li>












<li>
<a href="/knowledge/160900/vertigo-causes-symptoms-treatments" title="Everything you need to know about vertigo" class="keywords">vertigo</a> (dizziness)</li>












<li>lack of appetite</li>












<li>weight loss</li>












</ul>
<li>
<strong>Can occur with both Zytiga and Xtandi</strong>:</li>












<ul>
<li>joint pain</li>












<li>headache</li>












<li>fatigue (lack of energy)</li>












<li>flushing (warmth and redness in your skin)</li>












<li>diarrhea</li>












<li>edema (swelling, typically in your hands, legs, and feet)</li>












<li>nausea</li>












<li>vomiting</li>












<li>upper respiratory infection (sinus infection or common cold)</li>












</ul>
</ul>
<p><strong>Serious side effects</strong></p>












<p>These lists contain examples of serious side effects that can occur with Zytiga, Xtandi, or with both drugs (when taken individually).</p>












<ul>
<li>
<strong>Can occur with Zytiga</strong>:</li>












<ul>
<li>anemia (low level of red blood cells)</li>












<li>electrolyte disorders (such as low potassium levels)</li>












<li>high cholesterol and triglyceride levels</li>












<li>liver damage or liver failure</li>












<li>adrenal problems, such as low cortisol levels</li>












<li>cardiac disorders, including abnormal heart rhythm and cardiac arrest (your heart stops beating)</li>












<li>urinary tract infections</li>












<li>kidney problems</li>












</ul>
<li>
<strong>Can occur with Xtandi</strong>:</li>












<ul>
<li>seizures</li>












<li>neurological disorder affecting the brain</li>












<li>ischemic <a href="/articles/237191.php" title="Everything you need to know about heart disease" class="keywords">heart disease</a> (lack of blood flow to the heart)</li>












<li>falls and <a href="/articles/173312.php" title="What is a fracture?" class="keywords">fractures</a>
</li>












</ul>
<li>
<strong>Can occur with both Zytiga and Xtandi</strong>:</li>












<ul>
<li>severe allergic reaction</li>












<li>
<a href="/articles/150109.php" title="Everything you need to know about hypertension" class="keywords">hypertension</a> (high blood pressure)</li>












<li>high blood sugar levels</li>












</ul>
</ul>
<h3>Effectiveness</h3>












<p>These drugs haven't been directly compared in clinical studies, but studies have found both <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513" target="_blank" rel="noopener">Zytiga</a> and <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf" target="_blank" rel="noopener">Xtandi</a> to be effective for treating metastatic castration-resistant prostate cancer.</p>












<p>The <a href="https://www.auanet.org/guidelines/prostate-cancer-castration-resistant-(2013-amended-2018)" target="_blank" rel="noopener">American Urological Association</a>, the <a href="https://www.nccn.org/patients/guidelines/prostate/index.html" target="_blank" rel="noopener">National Comprehensive Cancer Network</a>, and the <a href="https://www.asco.org/practice-guidelines/quality-guidelines/guidelines/genitourinary-cancer#/25251" target="_blank" rel="noopener">American Society of Clinical Oncology</a> all recommend either Zytiga or Xtandi as treatment options for metastatic CRPC.</p>












<h3>Costs</h3>












<p>Zytiga and Xtandi are both brand-name drugs. There's currently a generic form of Zytiga, but there isn't a generic form of Xtandi. Brand-name medications usually cost more than generics.</p>












<p>The brand-name form of Zytiga costs much more than the generic form.</p>












<p>According to estimates from <a href="https://www.wellrx.com/" target="_blank" rel="noopener">WellRx.com</a>, the brand-name form of Zytiga generally costs less than Xtandi. The actual price you pay will depend on your insurance plan, your location, and the pharmacy you use.</p>












 <span class="anchor" id="zytiga-vs-other-drugs"></span>
<h2>Zytiga vs. other drugs</h2>












<p>You may wonder how Zytiga compares to other medications that are prescribed for similar uses. Below are comparisons between Zytiga and several medications.</p>












<h3>Zytiga vs. Casodex</h3>












<p>Zytiga contains the drug abiraterone acetate. Casodex contains the drug bicalutamide.</p>












<p>Both drugs decrease the activity of male hormones, but they work in different ways. Zytiga prevents the production of certain male hormones. Casodex blocks male hormones from attaching to their receptors (proteins on prostate cancer cells). Both actions help stop the spread of prostate cancer.</p>












<p><strong>Uses</strong></p>












<p>Both Zytiga and Casodex are used to treat metastatic prostate cancer. Metastatic prostate cancer has spread from the prostate to other areas of the body.</p>












<p>The Food and Drug Administration (FDA) has approved Zytiga to treat metastatic castration-resistant prostate cancer (CRPC). Metastatic CRPC continues to grow despite the use of drugs that lower male hormone levels.</p>












<p>Zytiga is also approved to treat metastatic high-risk castration-sensitive prostate cancer. This type of prostate cancer still responds to drugs that lower male hormone levels.</p>












<p>Casodex is FDA-approved to treat stage D2 metastatic prostate cancer. Stage D2 prostate cancer has metastasized (spread) to more distant bones, like the spine or ribs.</p>












<p><strong>Drug forms and administration</strong></p>












<p>Zytiga and Casodex are both given as pills. You take them once a day.</p>












<p>Zytiga comes in two strengths: a 250-mg tablet and a 500-mg tablet. The usual dosage is 1,000 mg once a day. You should take the drug without food (on an empty stomach). You take Zytiga with prednisone (a corticosteroid) to reduce certain side effects.</p>












<p>You may need a different dose of Zytiga if you're taking certain drugs that can affect Zytiga levels in the body or if you have liver disease.</p>












<p>Casodex comes as a 50-mg tablet. The usual dosage is 50 mg of Casodex once a day.</p>












<p>Both drugs must be taken with either additional hormone therapy or after surgery to remove your testicles. This helps further reduce the effects of androgens (male hormones such as testosterone) on prostate cancer cells.</p>












<p><strong>Side effects and risks</strong></p>












<p>Zytiga and Casodex work in different ways in the body. Therefore, they have some similar and some different common and serious side effects.</p>












<p><em><strong>More common side effects</strong></em></p>












<p>These lists contain examples of more common side effects that can occur with Zytiga, Casodex, or with both drugs (when taken individually).</p>












<ul>
<li>
<strong>Can occur with Zytiga</strong>:</li>












<ul>
<li>joint pain</li>












<li>fatigue (lack of energy)</li>












</ul>
<li>
<strong>Can occur with Casodex</strong>:</li>












<ul>
<li>body pain (in back, stomach, or pelvis)</li>












<li>weakness</li>












<li><a href="/articles/150322.php" title="What to know about constipation" class="keywords">constipation</a></li>












<li>shortness of breath</li>












<li>dizziness</li>












<li>blood in urine</li>












</ul>
<li>
<strong>Can occur with both Zytiga and Casodex</strong>:</li>












<ul>
<li>flushing (warmth and redness in your skin)</li>












<li>upper respiratory infection, such as a sinus infection or common cold</li>












<li>nausea</li>












<li>edema (swelling, typically in your hands, feet, and legs)</li>












<li>diarrhea</li>












<li>cough</li>












<li>headache</li>












<li>vomiting</li>












<li>needing to urinate often at night</li>












</ul>
</ul>
<p><em><strong>Serious side effects</strong></em></p>












<p>These lists contain examples of serious side effects that can occur with Zytiga, Casodex, or with both drugs (when taken individually).</p>












<ul>
<li>
<strong>Can occur with Zytiga</strong>:</li>












<ul>
<li>hypertension (high blood pressure)</li>












<li>electrolyte disorders (such as low potassium levels)</li>












<li>high cholesterol and triglyceride levels</li>












<li>adrenal problems, such as low cortisol levels</li>












<li>cardiac disorders, such as abnormal heart rhythm or cardiac arrest (your heart stops beating)</li>












<li>urinary tract infections</li>












<li>kidney problems</li>












</ul>
<li>
<strong>Can occur with Casodex</strong>:</li>












<ul>
<li>breast growth and pain</li>












</ul>
<li>
<strong>Can occur with both Zytiga and Casodex</strong>:</li>












<ul>
<li>severe allergic reaction</li>












<li>anemia (low level of red blood cells)</li>












<li>liver damage or liver failure</li>












<li>high blood sugar levels</li>












</ul>
</ul>
<p><strong>Effectiveness</strong></p>












<p>These drugs haven't been directly compared in clinical studies, but studies have found both Zytiga and Casodex to be effective for treating metastatic castration-resistant prostate cancer (CRPC).</p>












<p>The National Comprehensive Cancer Network recommends both Zytiga and Casodex as treatment options for metastatic CRPC.</p>












<p><strong>Costs</strong></p>












<p>Zytiga and Casodex are both brand-name drugs. There are generic forms of both Zytiga and Casodex. Brand-name medications usually cost more than generics.</p>












<p>According to estimates from <a href="https://www.wellrx.com/" target="_blank" rel="noopener">WellRx.com</a>, brand-name Zytiga and generic Zytiga generally cost more than either form of Casodex. The actual cost you pay for the drug will depend on your insurance plan, your location, and the pharmacy you use.</p>












<h3>Zytiga vs. Yonsa</h3>












<p>Zytiga and Yonsa contain the same drug: abiraterone acetate. But Yonsa was created as a much smaller particle of abiraterone acetate so your bloodstream can better absorb the drug. You can take Yonsa with or without food because of its smaller particle size.</p>












<p><strong>Uses</strong></p>












<p>Zytiga and Yonsa are both FDA-approved to treat metastatic castration-resistant prostate cancer (CRPC). Metastatic prostate cancer has spread from the prostate to other areas in the body. Metastatic CRPC continues to grow despite therapy that lowers male hormone levels.</p>












<p>Zytiga is also FDA-approved to treat metastatic high-risk castration-sensitive prostate cancer (CSPC). CSPC still responds to drug therapy that lowers male hormone levels.</p>












<p><strong>Drug forms and administration</strong></p>












<p>Zytiga and Yonsa are both given as pills once a day.</p>












<p>Zytiga comes in two strengths: a 250-mg tablet and a 500-mg tablet. The usual dosage is 1,000 mg once a day. You should take Zytiga without food (on an empty stomach). You take the drug with prednisone (a corticosteroid) to reduce certain side effects.</p>












<p>Your doctor may prescribe a different dose of Zytiga if you're taking certain drugs that affect Zytiga levels in your body or if you have liver disease.</p>












<div id="middle-of-article"></div>
<p>Yonsa comes as a 125-mg tablet. The usual dosage is 500 mg of Yonsa once a day. You take Yonsa with methylprednisolone (a corticosteroid) to reduce certain side effects.</p>












<p>Both drugs must be taken with either additional hormone therapy or after surgery to remove your testicles. This helps further reduce the effects that androgens (male hormones such as testosterone) have on cancer cells.</p>












<p><strong>Side effects and risks</strong></p>












<p>Zytiga and Yonsa are very similar drugs, therefore they have many of the same side effects.</p>












<p><em><strong>More common side effects</strong></em></p>












<p>This lists contains examples of more common side effects that can occur with Zytiga and Yonsa:</p>












<ul>
<li>joint pain or swelling</li>












<li>cough</li>












<li>diarrhea</li>












<li>edema (swelling, typically in your hands, legs, and feet)</li>












<li>fatigue (lack of energy)</li>












<li>flushing (warmth and redness in your skin)</li>












<li>nausea or vomiting</li>












<li>upper respiratory infection, such as a sinus infection or common cold</li>












<li>headaches</li>












<li>shortness of breath</li>












<li>bruising</li>












</ul>
<p><em><strong>Serious side effects</strong></em></p>












<p>These lists contain examples of serious side effects that can occur with both Zytiga and Yonsa:</p>












<ul>
<li>hypertension (high blood pressure)</li>












<li>anemia (low level of red blood cells)</li>












<li>high cholesterol and triglyceride levels</li>












<li>electrolyte disorders (such as low potassium levels)</li>












<li>high blood sugar levels</li>












<li>adrenal problems, such as low cortisol levels</li>












<li>urinary tract infections</li>












<li>liver damage or liver failure</li>












<li>cardiac disorders, such as abnormal heart rhythm or cardiac arrest (your heart stops beating)</li>












<li>kidney problems</li>












<li>low levels of white blood cells</li>












</ul>
<p><strong>Effectiveness</strong></p>












<p>These drugs haven't been directly compared in clinical studies, but studies have found both Zytiga and Yonsa to be effective for treating metastatic castration-resistant prostate cancer.</p>












<p><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513" target="_blank" rel="noopener">Zytiga</a> and <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8967e10-f768-47ce-ac9e-2324c8390132" target="_blank" rel="noopener">Yonsa</a> are two versions of the same drug. Yonsa was created as a much smaller particle of abiraterone acetate so your bloodstream can better absorb the drug. You can take Yonsa with or without food because of its smaller particle size. But you can expect the two drugs to have very similar effects on the body.</p>












<p>The <a href="https://www.nccn.org/patients/guidelines/prostate/index.html" target="_blank" rel="noopener">National Comprehensive Cancer Network</a> recommends both Zytiga and Yonsa as treatment options for metastatic CRPC.</p>












<p><strong>Costs</strong></p>












<p>Zytiga and Yonsa are both brand-name drugs. There are currently no generic forms of Yonsa, but there is a generic form of Zytiga available. Brand-name medications usually cost more than generics.</p>












<p>According to estimates from <a href="https://www.wellrx.com/" target="_blank" rel="noopener">WellRx.com</a>, brand-name Zytiga and generic Zytiga generally cost more than Yonsa. The actual cost you pay for the drug will depend on your insurance plan, your location, and the pharmacy you use.</p>












 <span class="anchor" id="-zytiga-and-prednisone"></span>
<h2>Zytiga and prednisone</h2>












<p>You take Zytiga with another drug called prednisone. Prednisone is a prescription corticosteroid medication.</p>












<p>Zytiga prevents your adrenal glands (which make and release hormones) from making cortisol. Cortisol is a hormone that plays a role in many important bodily functions. Some of these include maintaining <a href="/articles/270644.php" title="What is a normal blood pressure?" class="keywords">blood pressure</a>, regulating sleep-wake cycles, and controlling blood sugar levels.</p>












<p>Prednisone helps replace low cortisol levels, so it keeps these important bodily functions working properly. Prednisone also helps you avoid the side effects of low cortisol levels. That's why you take prednisone and Zytiga together.</p>












<p>If you have metastatic castration-resistant prostate cancer, you will take 5 mg of prednisone twice a day.</p>












<p>If you have metastatic high-risk castration-sensitive prostate cancer, you will take 5 mg of prednisone once a day.</p>












 <span class="anchor" id="-use-with-other-drugs"></span>
<h2>Zytiga use with other drugs</h2>












<p>You typically take Zytiga with prednisone and another hormone therapy drug. This second type of hormone therapy is referred to as androgen deprivation therapy (ADT). ADT medications help prevent the testicles from making male hormones that encourage prostate cancer to grow.</p>












<p>The adrenal glands and prostate cancer cells themselves also make male hormones in small amounts. Zytiga helps prevent these secondary areas of the body from producing testosterone.</p>












<p>Examples of ADT drugs include:</p>












<ul>
<li>leuprolide acetate (Eligard)</li>












<li>goserelin acetate (Zoladex)</li>












<li>histrelin acetate (Vantas)</li>












<li>degarelix (Firmagon)</li>












</ul>
<span class="anchor" id="zytiga-and-alcohol"></span>
<!--[DLB]--><div id="hl-incontent-video-ad"></div>
<div id="div-gpt-ad-out-of-page"></div>
<script type="text/javascript">
	googleAdSlotInfo.push({
		"slotName":'out-of-page',
		"slotContainer":'div-gpt-ad-out-of-page'	});
</script><!--[END DLB]--><!--[MMR]--><!--[END MMR]--><h2>Zytiga and alcohol</h2>












<p>There's no interaction between Zytiga and alcohol. But Zytiga has caused liver toxicity (dangerous levels of the drug that build up in the liver) in some people. Drinking too much alcohol may increase the risk of liver damage in people who are taking Zytiga.</p>












<p>If you take Zytiga, talk with your doctor about whether drinking alcohol is safe for you.</p>












 <span class="anchor" id="interactions"></span>
<h2>Zytiga interactions</h2>












<p>Zytiga can interact with several other medications. It can also interact with certain supplements and foods.</p>












<p>Different interactions can cause different effects. For instance, some interactions can affect how well a drug works, while others can increase the number of side effects or make them more severe.</p>












<h3>Zytiga and other medications</h3>












<p>Below is a list of medications that can interact with Zytiga. This list does not contain all drugs that may interact with Zytiga.</p>












<p>Before taking Zytiga, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.</p>












<p>If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.</p>












<p><strong>Zytiga and Xofigo</strong></p>












<p>Don't take Zytiga with Xofigo, a radioactive medication, unless you're taking them together in a clinical trial. In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a398400e-bd31-41a9-9696-4f7c06569ede" target="_blank" rel="noopener">clinical study</a>, people who took Zytiga with Xofigo had a greater risk for bone fractures and death. This was compared to people who took Zytiga and a <a href="/articles/306437.php" title="Placebos: The power of the placebo effect" class="keywords">placebo</a> (a dummy drug that doesn't work). If you have questions about Xofigo, talk with your doctor.</p>












<p><strong>Zytiga and Provenge</strong></p>












<p>There's no interaction between Zytiga and Provenge (sipuleucel-T). Provenge is a type of vaccine that makes your immune system more active in fighting prostate cancer.</p>












<p>One <a href="http://clincancerres.aacrjournals.org/content/21/17/3862.long" target="_blank" rel="noopener">clinical study</a> looked at how people's immune systems responded to Provenge therapy. An immune system response shows that Provenge is working. The results of this study were similar in people who took Zytiga with Provenge and in people who used Zytiga after taking Provenge.</p>












<p>However, current <a href="https://www.nccn.org/patients/guidelines/prostate/index.html" target="_blank" rel="noopener">treatment guidelines</a> don't recommend using Zytiga and Provenge together. Instead, the guidelines recommended taking one drug or the other as a possible treatment.</p>












<p><strong>Zytiga and certain seizure medications</strong></p>












<p>Taking Zytiga with certain seizure medications can increase how quickly your body gets rid of Zytiga. This can lower the amount of Zytiga in your body and make the drug less effective (not work as well). Examples of these seizure medications include:</p>












<ul>
<li>phenytoin (Dilantin, Phenytek)</li>












<li>carbamazepine (Carbatrol, Epitol, Equetro, Tegretol, Tegretol-XR, or Teril)</li>












<li>phenobarbital</li>












</ul>
<p>In some instances, your doctor may want you to take Zytiga with one of these seizure medications. If that's the case, they may increase your Zytiga dose to 1,000 mg twice a day.</p>












<p><strong>Zytiga and certain tuberculosis medications</strong></p>












<p>Taking Zytiga with certain <a href="/articles/8856.php" title="All you need to know about tuberculosis" class="keywords">tuberculosis</a> medications can increase how quickly your body gets rid of Zytiga. This may make Zytiga less effective (not work as well) by lowering the amount of the drug in your body. Examples of these tuberculosis medications include:</p>












<ul>
<li>rifampin (Rifadin, Rimactane)</li>












<li>rifabutin (Mycobutin)</li>












<li>rifapentine (Priftin)</li>












</ul>
<p>In some instances, your doctor may want you to take Zytiga with one of these tuberculosis medications. If that's the case, they may increase your Zytiga dose to 1,000 mg twice a day.</p>












<p><strong>Zytiga and drugs that are broken down by the enzyme CYP2D6</strong></p>












<p>Taking Zytiga with drugs that are metabolized (broken down) by the enzyme CYP2D6 can increase the levels of those drugs in your body. (An enzyme is a protein that causes chemical reactions in your body.) This is because Zytiga blocks CYP2D6 from breaking down those drugs the way the enzyme normally would. Higher levels of these drugs may increase your risk for side effects.</p>












<p>Examples of drugs broken down by CYP2D6 include:</p>












<ul>
<li>dextromethorphan (Delsym)</li>












<li>certain <a href="/kc/antidepressants-work-248320" title="All about antidepressants" class="keywords">antidepressants</a>, such as desipramine (Norpramin), nortriptyline (Pamelor), and venlafaxine (Effexor XR, Pristiq)</li>












<li>atomoxetine (Strattera)</li>












<li>thioridazine</li>












<li>nebivolol (Bystolic)</li>












</ul>
<p>If you're taking Zytiga with a drug that's metabolized by CYP2D6, your doctor will closely monitor your side effects. You may need a lower dose of Zytiga or an alternative for the other medication.</p>












<p><strong>Zytiga and drugs that are broken down by the protein CYP2C8</strong></p>












<p>Taking Zytiga with drugs that are metabolized (broken down) by the protein CYP2C8 can increase the levels of those drugs in your body. This is because Zytiga blocks CYP2C8 from breaking down those drugs the way the protein normally would. Higher levels of these drugs can increase your risk for side effects.</p>












<p>Examples of these drugs include pioglitazone (Actos) and repaglinide (Prandin).</p>












<p>If you're taking Zytiga with a drug that's broken down by CYP2C8, your doctor will monitor you closely for side effects. You may need an alternative to that medication or a lower dose of Zytiga.</p>












<p><strong>Zytiga and St. John's wort</strong></p>












<p>Taking Zytiga with <a href="https://www.healthline.com/health-news/is-st-johns-wort-safe-080615#1" target="_blank" rel="noopener">St. John's wort</a> can decrease the amount of Zytiga in your body. This is because St. John's wort increases how quickly your body gets rid of Zytiga. Low levels of Zytiga can decrease how well it will work for you.</p>












<p>In some instances, your doctor may want you to take Zytiga and St. John's wort. If that's the case, your doctor may increase your Zytiga dose to 1,000 mg twice a day.</p>












<h3>Zytiga and foods</h3>












<p>Don't take Zytiga at the same time that you eat food. Eating food when you take the drug will increase the amount of Zytiga that your body absorbs (takes in) at one time. This increases your risk for side effects. Take Zytiga either one hour before a meal or two hours after a meal.</p>












<p>However, according to current <a href="https://www.nccn.org/patients/guidelines/prostate/index.html" target="_blank" rel="noopener">treatment guidelines</a>, taking Zytiga with food may be an option. Talk with your doctor if you have questions.</p>












 <span class="anchor" id="how-to-take"></span>
<h2>How to take Zytiga</h2>












<p>You should take Zytiga according to your doctor or healthcare provider's instructions.</p>












<h3>Timing</h3>












<p>Take Zytiga once a day, either one hour before a meal or two hours after a meal. Taking the medication at the same time each day can help you remember your dose.</p>












<p>And medication reminders can help make sure that you don't miss a dose.</p>












<h3>Taking Zytiga with food</h3>












<p>Take Zytiga on an empty stomach, either one hour before a meal or two hours after a meal. Taking Zytiga on an empty stomach helps decrease your risk for side effects.</p>












<p>Take your dose of Zytiga with a glass of water.</p>












<p>However, according to current <a href="https://www.nccn.org/patients/guidelines/prostate/index.html" target="_blank" rel="noopener">treatment guidelines</a>, taking Zytiga with food may be an option. Talk with your doctor if you have questions.</p>












<h3>Can Zytiga be crushed, split, or chewed?</h3>












<p>No. You shouldn't crush, split, or chew Zytiga. You must swallow it whole.</p>












 <span class="anchor" id="how-it-works"></span>
<h2>How Zytiga works</h2>












<p>Zytiga contains the drug abiraterone acetate, which is used to treat two types of metastatic prostate cancer:</p>












<ul>
<li>
<strong>Metastatic castration-resistant prostate cancer</strong>.* This is prostate cancer that has metastasized (spread) from the prostate to another area in the body. It's castration-resistant, which means it keeps growing despite drug therapy or surgery that lowers testosterone levels.</li>












<li>
<strong>Metastatic high-risk castration-sensitive prostate cancer</strong>. This is also prostate cancer that has metastasized (spread) from the prostate to another area in the body. High-risk prostate cancer is expected to grow and spread quickly. Castration-sensitive prostate cancer responds to drug therapy or surgery that lowers testosterone levels.</li>












</ul>
<p><em>* The word "castration" is used because drug therapy is considered an alternative to surgically removing the testicles. Both of these methods decrease testosterone levels.</em></p>












<p>Androgens (male hormones such as testosterone) encourage prostate cancer cells to grow. Zytiga belongs to a class of medications called androgen biosynthesis inhibitors. These drugs inhibit (block) the production of androgens.</p>












<p>Specifically, Zytiga blocks the activity of an enzyme (a protein that causes chemical reactions in the body) called CYP17. The CYP17 enzyme is involved in the production of testosterone and other male hormones. These hormones are made in the testicles, the adrenal glands, and prostate cancer cells.</p>












<p>Zytiga decreases the amount of testosterone that prompts cancer to grow. But it doesn't block all testosterone production in the body, so you need to take Zytiga with other hormone therapy.</p>












<h3>How long does it take to work?</h3>












<p>Each person's body will respond differently to Zytiga. But drugs like Zytiga that affect steroid hormones may start to lower testosterone levels in days to weeks. Because the goal of Zytiga treatment is to stop the growth of cancer, it's not possible to say for sure how quickly the lower testosterone levels will affect cancer cells.</p>












 <div id="threequarter-of-article"></div>
<span class="anchor" id="pregnancy"></span>
<!--[MMR]--><!--[END MMR]--><h2>Zytiga and pregnancy</h2>












<p>Zytiga isn't intended for use by women.</p>












<p>Pregnant women shouldn't take or handle Zytiga. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S8.1" target="_blank" rel="noopener">animal studies</a>, taking Zytiga while pregnant had harmful and fatal effects on offspring.</p>












<p>Women who are pregnant or may become pregnant must wear protective gloves while handling Zytiga 250-mg uncoated tablets or damaged Zytiga 500-mg coated tablets. Unprotected exposure to the drug may harm the developing baby.</p>












<p>If men who are taking Zytiga are sexually active with a pregnant woman, they should use a condom during treatment and for three weeks after the final dose. If they have female partners who can become pregnant, the couple should use two forms of <a href="/articles/162762.php" title="What types of birth control are there?" class="keywords">birth control</a> (for example, condoms and oral birth control pills).</p>












<p>In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S13.1" target="_blank" rel="noopener">animal studies</a>, males who were given Zytiga had reduced fertility (ability to make a woman pregnant). This effect was reversible after 16 weeks following the last dose. But animal studies don't always predict what will occur in humans.</p>












 <span class="anchor" id="breastfeeding"></span>
<h2>Zytiga and breastfeeding</h2>












<p>It's not known whether Zytiga passes into breast milk.</p>












<p>If you're considering taking Zytiga while you're breastfeeding, talk with your doctor. They may recommend that you either stop breastfeeding or take a drug other than Zytiga.</p>












 <span class="anchor" id="faqs"></span>
<!--[DLB]--><!-- Leaderboard BANNER advert -->

<div id="dlb3_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb3_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB3',
			"slotContainer":'dlb3_container'		});
	</script>
	</div>
	

</div>






<!-- /header_ad code --><!--[END DLB]--><h2>Common questions about Zytiga</h2>












<p>Here are answers to some frequently asked questions about Zytiga.</p>












<h3>Can I use Zytiga after using Xtandi?</h3>












<p>Yes. You can take Zytiga after taking Xtandi.</p>












<p>According to current <a href="https://www.nccn.org/patients/guidelines/prostate/" target="_blank" rel="noopener">treatment guidelines</a>, Zytiga is a treatment option for people whose cancer got worse while taking Xtandi or after taking Xtandi.</p>












<p>On the other hand, Xtandi is a treatment option for people whose cancer got worse while taking Zytiga or after taking Zytiga.</p>












<h3>Can I take Zytiga without prednisone?</h3>












<p>It's recommended that you take Zytiga with the corticosteroid prednisone to reduce some of the side effects that happen because of low hormone levels. Some of these side effects include high blood pressure, low potassium levels, and edema (swelling, typically in your hands, legs, and feet).</p>












<p>In one <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1702900" target="_blank" rel="noopener">clinical study</a>, people took prednisolone (a corticosteroid that's similar to prednisone) with Zytiga. In another <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129174/" target="_blank" rel="noopener">clinical study</a> involving older adults, Zytiga was taken with either prednisone or prednisolone. These combinations were found to be safe and effective for treating metastatic prostate cancer when taken with standard hormone therapy.</p>












<p>And in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560791/" target="_blank" rel="noopener">another study</a>, switching from prednisone to dexamethasone (a corticosteroid similar to prednisone) was safe for people with advanced cancer.</p>












<p>A small <a href="https://www.ncbi.nlm.nih.gov/pubmed/30427533" target="_blank" rel="noopener">clinical study</a> found that some people may be able to take Zytiga without prednisone. However, they'll need to be monitored more closely by their doctor. Don't stop taking prednisone unless your doctor tells you to do so.</p>












<p>Some doctors may also prescribe a different corticosteroid, such as prednisolone, methylprednisolone, or dexamethasone, that you take with Zytiga. Prescribing a different corticosteroid than the one the Food and Drug Administration (FDA) approved is considered off-label use.</p>












<h3>Is Zytiga a form of chemotherapy?</h3>












<p>No. Zytiga isn't a form of <a href="/articles/158401.php" title="What you need to know about chemotherapy" class="keywords">chemotherapy</a>. Zytiga is a type of hormone therapy that helps fight prostate cancer. It works by reducing the amount of male hormones in the body.</p>












<p>Chemotherapy drugs, such as docetaxel (Taxotere) or cabazitaxel (Jevtana), work differently from hormone therapy drugs. Chemotherapy drugs attack many different types of rapidly growing cells in the body, including cancer cells. But the drugs also attack newly forming blood cells, hair follicle cells, and cells on the linings of the mouth and intestines. Chemotherapy drugs typically have many side effects because of how they affect the body.</p>












<p>Hormone therapy is usually a first-choice therapy for treating prostate cancer. Chemotherapy can be used with hormone therapy or by itself to treat late-stage cancer. However, Zytiga isn't one of the hormone therapies currently recommended to be used in combination with chemotherapy.</p>












<h3>How long will I need to be treated with Zytiga?</h3>












<p>You and your doctor will discuss how effective and safe Zytiga is for you. You will likely take Zytiga for as long as it helps prevent cancer from growing and for as long as you can handle the side effects. This may be anywhere from months to years.</p>












<h3>Does Zytiga affect my testosterone levels?</h3>












<p>Yes. Zytiga helps slow or stop the growth of prostate cancer by decreasing the amount of testosterone and other male hormones in your body. Zytiga lowers testosterone levels by blocking the production of other steroids that help create testosterone. It also lowers the levels of another important male hormone called dihydrotestosterone.</p>












<h3>What is the life expectancy for someone taking Zytiga?</h3>












<p>Life expectancy (the number of years you will likely live) is based on several factors. These include your age, overall health status, the stage (how advanced) your cancer is, and other factors. Life expectancy is different for every person. The number of years you will likely live will help guide therapy options for your prostate cancer.</p>












<p>In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513#S5.1" target="_blank" rel="noopener">clinical studies</a>, people with metastatic castration-resistant prostate cancer who took Zytiga lived about 4.5 months longer than people who didn't take Zytiga. But each person's response to Zytiga treatment will be unique and based on their own life expectancy factors.</p>












 <span class="anchor" id="precautions"></span>
<h2>Zytiga precautions</h2>












<p>Before taking Zytiga, talk with your doctor about your health history. Zytiga may not be right for you if you have certain medical conditions. These include:</p>












<h3>Heart disease</h3>












<p>Zytiga may cause serious heart problems (such as <a href="/articles/151444.php" title="How to spot and treat a heart attack" class="keywords">heart attack</a> or <a href="/articles/7624.php" title="Everything you need to know about stroke" class="keywords">stroke</a>) and death. Before you start taking Zytiga, talk with your doctor about your history of heart disease. This includes <a href="/articles/156849.php" title="Congestive heart failure: What you need to know" class="keywords">heart failure</a>, <a href="/articles/8887.php" title="Arrhythmia: Causes, symptoms, types, and treatment" class="keywords">arrhythmia</a> (abnormal heart rhythm), and heart attack.</p>












<p>Your doctor will check you for heart disease, as well as for high blood pressure, low potassium levels, and <a href="/articles/187978.php" title="What to know about water retention" class="keywords">fluid retention</a> (see below). If needed, they'll recommend treatment for heart disease before and during your Zytiga treatment. Zytiga may not be right for people with a very high risk for serious heart problems.</p>












<h3>Hypertension</h3>












<p>Zytiga can cause hypertension (high blood pressure), which increases your risk for heart problems such as heart attack or stroke.</p>












<p>Your doctor will check your blood pressure before you start Zytiga and at least once a month while you take the drug. If needed, they'll recommend treatment options to control your blood pressure before and during your Zytiga treatment.</p>












<h3>Hypokalemia</h3>












<p>Zytiga can decrease blood levels of potassium. This is an important electrolyte (a mineral) that your body needs for proper nerve, muscle, and heart function.</p>












<p>Your doctor will check your potassium levels before you start Zytiga and at least once a month while you take the drug. If needed, they'll recommend treatment options to correct your potassium levels before and during your Zytiga treatment.</p>












<h3>Edema or fluid retention</h3>












<p>Zytiga can cause edema (swelling, typically in your hands, legs, and feet).</p>












<p>Before starting Zytiga, tell your doctor about any swelling that you have. They will check to see if the swelling is caused by a disease that should be treated before you start taking Zytiga. If needed, they'll recommend treatment options to help prevent edema before or during your Zytiga treatment.</p>












<h3>Adrenal insufficiency</h3>












<p>Zytiga and prednisone (a corticosteroid drug that you take with Zytiga) have been linked to adrenal problems. (Adrenal glands make and release hormones.) The link was very strong in people who were under stress, had an infection, or stopped corticosteroid therapy.</p>












<p>Before starting Zytiga, tell your doctor if you've had adrenal problems in the past. They may monitor you more closely for side effects or recommend an alternate therapy.</p>












<h3>Pituitary disorders</h3>












<p>Zytiga works on hormones that are partly controlled by the pituitary gland.</p>












<p>Before starting Zytiga, tell your doctor if you've had pituitary problems in the past. They may monitor you more closely while you take Zytiga.</p>












<h3>Liver disease or liver problems</h3>












<p>Zytiga has been linked to liver damage, <a href="/articles/145869.php" title="What's to know about viral hepatitis?" class="keywords">hepatitis</a>, liver failure, and death. People who had liver disease or liver problems in the past have a greater risk of liver damage if they take Zytiga.</p>












<p>Your doctor will check how your liver is working before you start Zytiga. They'll continue to check your liver function every two weeks for three months, and then every month after that. If you develop liver problems during treatment, you may need to stop taking Zytiga for a time or take a lower dose.</p>












<p>People with moderate liver disease should start with a lower dose of Zytiga. People with severe liver disease shouldn't take Zytiga.</p>












 <span class="anchor" id="overdose"></span>
<!--[MMR]--><!--[END MMR]--><h2>Zytiga overdose</h2>












<p>Taking more than the recommended dosage of Zytiga can increase your risk for common and serious side effects. This list does not include all possible overdose symptoms.</p>












<h3>Overdose symptoms</h3>












<p>Symptoms of an overdose can include:</p>












<ul>
<li>diarrhea</li>












<li>nausea and vomiting</li>












<li>high blood pressure</li>












<li>abnormal heart rhythm</li>












<li>cardiac arrest (your heart stops beating)</li>












<li>liver damage or liver failure</li>












</ul>
<h3>What to do in case of overdose</h3>












<p>If you think you've taken too much of this drug, call your doctor. You can also call the American Association of Poison Control Centers at 800-222-1222 or use their <a href="https://www.poisonhelp.org/help" target="_blank" rel="noopener">online tool</a>. But if your symptoms are severe, call 911 or go to the nearest emergency room right away.</p>












 <span class="anchor" id="expiration"></span>
<h2>Zytiga expiration, storage, and disposal</h2>












<p>When you get Zytiga from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically one year from the date they dispensed the medication.</p>












<p>The expiration date helps guarantee the effectiveness of the medication during this time. The <a href="https://www.fda.gov/drugs/resourcesforyou/specialfeatures/ucm481139.htm" target="_blank" rel="noopener">current stance</a> of the Food and Drug Administration (FDA) is to avoid using expired medications. If you have unused medication that has gone past the expiration date, talk with your pharmacist about whether you might still be able to use it.</p>












<h3>Storage</h3>












<p>How long a medication remains good can depend on many factors, including how and where you store the medication.</p>












<p>Store Zytiga pills at room temperature (68°F to 77°F/20°C to 25°C) away from the reach of children.</p>












<h3>Disposal</h3>












<p>If you no longer need to take Zytiga and have leftover medication, it's important to dispose of it safely. This helps prevent others, including children and pets, from taking the drug by accident. It also helps keep the drug from harming the environment.</p>












<p>The <a href="https://www.fda.gov/consumers/consumer-updates/where-and-how-dispose-unused-medicines" target="_blank" rel="noopener">FDA website</a> provides several useful tips on medication disposal. You can also ask your pharmacist for information on how to dispose of your medication.</p>












 <span class="anchor" id="professional-information"></span>
<h2>Professional information for Zytiga</h2>












<p>The following information is provided for clinicians and other healthcare professionals.</p>












<h3>Indications</h3>












<p>Zytiga is approved by the Food and Drug Administration (FDA) to be used in combination with prednisone for the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.</p>












<h3>Mechanism of action</h3>












<p>Zytiga contains the prodrug abiraterone acetate, which is an androgen biosynthesis inhibitor. It's converted through hydrolysis to the active metabolite abiraterone.</p>












<p>Zytiga inhibits the enzyme 17α-hydroxylase/C17,20-lyase (CYP17), which is expressed in the testicles, adrenal glands, and prostatic <a href="/articles/249141.php" title="What are the different types of tumors?" class="keywords">tumor</a> tissue. Inhibition of the CYP17 enzyme decreases production of the testosterone precursors dehydroepiandrosterone (DHEA) and androstenedione, which ultimately lowers the levels of serum testosterone and dihydroxy testosterone.</p>












<p>Inhibition of CYP17 also increases mineralocorticoid production by the adrenal glands.</p>












<h3>Pharmacokinetics and metabolism</h3>












<p>Maximum plasma concentrations are reached two hours after oral administration of Zytiga. Meal fat composition significantly alters systemic exposure, so Zytiga should be taken on an empty stomach.</p>












<p>Zytiga is highly bound to plasma proteins (albumin and alpha-1 acid glycoprotein) and is metabolized via non-CYP mediated hydrolysis. Approximately 88% of the dose is excreted in feces. Terminal half-life is approximately 12 hours. Hepatic impairment prolongs exposure (see dosing adjustment recommendations).</p>












<p>Zytiga is a substrate of cytochrome P450 (CYP) 3A4 and an inhibitor of CYP2D6 and CYP2C8.</p>












<h3>Contraindications</h3>












<p>Zytiga can cause harm to a developing fetus and loss of pregnancy.</p>












<p>Note: Men with female partners of reproductive potential should use effective contraception during Zytiga treatment and for three weeks after the final dose.</p>












<h3>Storage</h3>












<p>Zytiga tablets should be stored at room temperature (68°F to 77°F/20°C to 25°C). Keep out of reach of children.</p>
<div id="bottom-of-article"></div>
 	</div> 	</div> 
<style type="text/css">
		/*.mnt_dlb_foot_container { display:block; width: 728px; height: 90px; }*/
		/*@media (min-width: 990px) { .mnt_dlb_foot_container { display: none; } }
		@media (min-width:1148px) { .mnt_dlb_foot_container { display:block;} }*/
</style>
<!-- MNT_Adsense_Desktop_728x90 Footer -->
<ins class="adsbygoogle mnt_dlb_foot_container"
	 id="mnt_dlb_foot_container"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-4771166113579725"
     data-ad-slot="9436500920"></ins>


<script>


	fireOrSaveJsFunctions(1,function(){loadScript(
		"//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js",
		{},
		function(){}

	)});


</script>
<script>(adsbygoogle = window.adsbygoogle || []).push({});</script>



<p id='slidebox_trigger'></p>

	<div id="suggest_reading_outer_container" class="place full">

		<h2 class="suggested_reading internal_related">Related coverage</h2>
	<span></span>
		<!--<h2 class="suggested_reading">Suggested Reading</h2>-->
	
	<div itemscope itemtype="http://schema.org/WebPage"> <!-- suggested_reading_container_parent -->
	<div class="suggested_reading_container ">
				<div class='suggested_reading_inner column1'>
				<div class="suggested_item">
		<a href="/articles/321801.php" title="Can women get prostate cancer?" class="related_coverage_link" data-id="321801">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/321/321801/321801_1100.jpg" alt="" />
		</div>
				<span class="title">Can women get prostate cancer?</span>
		<span class="summary">Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column2'>
				<div class="suggested_item">
		<a href="/articles/321079.php" title="What foods are good for an enlarged prostate?" class="related_coverage_link" data-id="321079">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/321/321079/321079_1100.jpg" alt="" />
		</div>
				<span class="title">What foods are good for an enlarged prostate?</span>
		<span class="summary">How does diet affect the prostate? In this article, learn about which foods to eat and which to avoid if you have an enlarged prostate gland.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column3'>
				<div class="suggested_item">
		<a href="/articles/318019.php" title="Immunotherapy for prostate cancer: What you need to know" class="related_coverage_link" data-id="318019">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/headlines/318/318019/scientists-working-in-a-lab.jpg" alt="" />
		</div>
				<span class="title">Immunotherapy for prostate cancer: What you need to know</span>
		<span class="summary">Immunotherapy is an emerging treatment for cancer that aims to boost the immune system cells' ability to fight off cancer. Immunotherapy approaches include programming immune cells to kill cancer and blocking the immune-system-numbing properties of cancer. Read on to learn more about this pioneering treatment.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column4'>
				<div class="suggested_item">
		<a href="/articles/322436.php" title="What are the treatment options for BPH?" class="related_coverage_link" data-id="322436">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/322/322436/322436_1100.jpg" alt="" />
		</div>
				<span class="title">What are the treatment options for BPH?</span>
		<span class="summary">Benign prostatic hyperplasia, or BPH, is the medical term for an enlarged prostate. BPH can cause difficulties with urination. Treatment options for BPH include watchful waiting, medication, minimally invasive procedures, and surgery. Lifestyle changes can also help improve a person’s symptoms. Learn more here.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column5'>
				<div class="suggested_item">
		<a href="/articles/324480.php" title="What to expect from Lupron treatment" class="related_coverage_link" data-id="324480">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/324/324480/324480_1100.jpg" alt="" />
		</div>
				<span class="title">What to expect from Lupron treatment</span>
		<span class="summary">Lupron (leuprolide acetate) is a type of hormone therapy for people with prostate cancer. Lupron is an injection drug, and doctors often prescribe it in combination with radiation therapy or surgery. As it lowers a person’s testosterone levels, Lupron can cause a range of side effects. Learn more here.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
				</div>
	</div>
	</div>
	

<div id="social_bottom"  >			
    <div id="share_social_bottom">    
        <div id="article_social_bottom_facebook" ></div>
        <div id="article_social_bottom_twitter" ></div>
        <div id="article_social_bottom_linkedin" ></div>

		    
    </div>
    <div class="toolbox">
		<div class="email">            <a rel="nofollow" title="email this article" href="#">
			<span class="toolbox_label">email</span></a>
            <span class="visuallyhidden">
            <a rel="nofollow" title="email this article" href="#">email</a>
            </span>
        </div>        
		        <div class="print">			            <a id="f081358743a248418811f2e44321a18e" href="#" rel="nofollow" title="View print preview" target="_blank">
			<span class="toolbox_label">print</span></a>
        </div>        		
		<div class="share">            <a rel="nofollow" title="share this article" href="#">
			<span class="toolbox_label">share</span></a>
            <span class="visuallyhidden">
            <a rel="nofollow" title="share this article" href="#">share</a>
            </span>
        </div>

    </div>

</div><a id="rate-this-article"></a>	<div class="article_category_container">
					<div class="article_main_category_container"> 
				<span itemprop="genre" class="category_main">
				<a href="/categories/prostate" title="Prostate / Prostate Cancer News" class="current">Prostate / Prostate Cancer</a>
				</span>
			</div> 					<div class="article_sub_category_container">
				</div> 	</div> 	                    <div class="widget_citation_group" id="widget_citation">

                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading active">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#additional">
                                        Additional information</a>
                                </h4>
                            </div>
                            <div id="additional" class="panel-collapse collapse in">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="additional" >

		<p> Article last reviewed by Sun 23 June 2019.<br><br>Visit our <a href='/categories/prostate' title='Visit our Prostate / Prostate Cancer category page'>Prostate / Prostate Cancer</a> category page for the latest news on this subject, or <a href='/newsletter' title='Sign up to our newsletter'>sign up to our newsletter</a> to receive the latest updates on Prostate / Prostate Cancer.<br><br>All references are available in the <b>References</b> tab.		</p>
	</ul>
	                                </div>
                            </div>
                        </div>


                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#references">
                                        References</a>
                                </h4>
                            </div>
                            <div id="references" class="panel-collapse collapse">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="references" >
		<noscript> 
		This content requires JavaScript to be enabled.<br/><br/> 
		</noscript>
		<p>
		<p>Adrenal insufficiency and Addison's disease. (n.d.). <a href="https://www.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease" target="_blank" rel="noopener">https://www.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease</a></p>
<p>The American Cancer Society medical and editorial content team. (2018). Hormone therapy for prostate cancer. <a href="https://www.cancer.org/cancer/prostate-cancer/treating/hormone-therapy.html" target="_blank" rel="noopener">https://www.cancer.org/cancer/prostate-cancer/treating/hormone-therapy.html</a></p>
<p>Auchus RJ, <em>et al</em>. (2014). Use of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancer. <a href="http://theoncologist.alphamedpress.org/content/19/12/1231" target="_blank" rel="noopener">http://theoncologist.alphamedpress.org/content/19/12/1231</a></p>
<p>Castration-resistant prostate cancer. (2018). <a href="https://www.auanet.org/guidelines/prostate-cancer-castration-resistant-(2013-amended-2018)" target="_blank" rel="noopener">https://www.auanet.org/guidelines/prostate-cancer-castration-resistant-(2013-amended-2018)</a></p>
<p>Casodex - bicalutamide tablet. (2018). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dfee4fe7-8478-4a3e-925d-00be3cd0ab67" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dfee4fe7-8478-4a3e-925d-00be3cd0ab67</a></p>
<p>Don't be tempted to use expired medicines. (2016). <a href="https://www.fda.gov/drugs/resourcesforyou/specialfeatures/ucm481139.htm" target="_blank" rel="noopener">https://www.fda.gov/drugs/resourcesforyou/specialfeatures/ucm481139.htm</a></p>
<p>Drug development and drug interactions: Table of substrates, inhibitors, and inducers. (2017). <a href="https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm" target="_blank" rel="noopener">https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm</a></p>
<p>Ingrosso G,<em> et al</em>. (2018). Current therapeutic options in metastatic castration-resistant prostate cancer. <a href="https://www.ncbi.nlm.nih.gov/pubmed/30446166" target="_blank" rel="noopener">https://www.ncbi.nlm.nih.gov/pubmed/30446166</a></p>
<p>James ND, <em>et al</em>. (2017). Abiraterone for prostate cancer not previously treated with hormone therapy. <a href="https://www.nejm.org/doi/10.1056/NEJMoa1702900" target="_blank" rel="noopener">https://www.nejm.org/doi/10.1056/NEJMoa1702900</a></p>
<p>McKay RR, <em>et al</em>. (2019). A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer. <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.31836" target="_blank" rel="noopener">https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.31836</a></p>
<p>NCCN Clinical practice guidelines in oncology: Prostate cancer. (2019). <a href="https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf" target="_blank" rel="noopener">https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf</a></p>
<p>NCCN Guidelines for patients: Prostate cancer. (2018). <a href="https://www.nccn.org/patients/guidelines/prostate/index.html" target="_blank" rel="noopener">https://www.nccn.org/patients/guidelines/prostate/index.html</a></p>
<p>Nutrition for the person with cancer during treatment. (n.d.). <a href="https://www.cancer.org/treatment/survivorship-during-and-after-treatment/staying-active/nutrition/nutrition-during-treatment.html" target="_blank" rel="noopener">https://www.cancer.org/treatment/survivorship-during-and-after-treatment/staying-active/nutrition/nutrition-during-treatment.html</a></p>
<p>Purshouse K, <em>et al</em>. (2019). Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: Clinical evidence and experience. <a href="https://journals.sagepub.com/doi/10.1177/1756287218820804" target="_blank" rel="noopener">https://journals.sagepub.com/doi/10.1177/1756287218820804</a></p>
<p>Roviello G, <em>et al</em>. (2018). Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone. <a href="https://link.springer.com/article/10.1007%2Fs10637-018-0685-7" target="_blank" rel="noopener">https://link.springer.com/article/10.1007%2Fs10637-018-0685-7</a></p>
<p>Schmid S, <em>et al</em>. (2014). Abiraterone - what is wrong with the adrenal glands? <a href="https://www.clinical-genitourinary-cancer.com/article/S1558-7673(14)00016-0/fulltext" target="_blank" rel="noopener">https://www.clinical-genitourinary-cancer.com/article/S1558-7673(14)00016-0/fulltext</a></p>
<p>Small EJ, <em>et al</em>. (2015). A randomized phase II trial of sipuleucel-T with concurrent versus abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer. <a href="http://clincancerres.aacrjournals.org/content/21/17/3862" target="_blank" rel="noopener">http://clincancerres.aacrjournals.org/content/21/17/3862</a></p>
<p>Smith MR, <em>et al</em>. (2015). Efficacy and safety of abiraterone acetate in elderly (≥75 years) chemotherapy-naïve patients with metastatic castration-resistant prostate cancer. <a href="https://www.auajournals.org/doi/10.1016/j.juro.2015.07.004" target="_blank" rel="noopener">https://www.auajournals.org/doi/10.1016/j.juro.2015.07.004</a></p>
<p>Virgo KS, <em>et al</em>. (2017). Second-line hormonal therapy for men with chemotherapy-naïve castration-resistant prostate cancer PCO. <a href="https://ascopubs.org/doi/10.1200/JCO.2017.72.8030" target="_blank" rel="noopener">https://ascopubs.org/doi/10.1200/JCO.2017.72.8030</a></p>
<p>WellRx. (n.d.). <a href="https://www.wellrx.com/" target="_blank" rel="noopener">https://www.wellrx.com/</a></p>
<p>Xtandi - enzalutamide capsule. (2018). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf</a></p>
<p>Yonsa - abiraterone acetate tablet. (2018). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8967e10-f768-47ce-ac9e-2324c8390132" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8967e10-f768-47ce-ac9e-2324c8390132</a></p>
<p>Zanardi E, <em>et al</em>. (2019). To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone. <a href="https://www.ncbi.nlm.nih.gov/pubmed/31217821" target="_blank" rel="noopener">https://www.ncbi.nlm.nih.gov/pubmed/31217821</a></p>
<p>Zytiga - abiraterone acetate tablet; Zytiga - abiraterone acetate tablet, film coated. (2019). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513</a></p>		</p>
	</ul>
	                                </div>
                            </div>
                        </div>


                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#citations">
                                        Citations</a>
                                </h4>
                            </div>
                            <div id="citations" class="panel-collapse collapse">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="citations" >
		<p>Please use one of the following formats to cite this article in your essay, paper or report:</p><p><strong>MLA</strong><br />Slowiczek, Lindsay. "Zytiga (abiraterone acetate)." <i>Medical News Today</i>. MediLexicon, Intl., 15 Aug. 2019. Web.<br>6 Sep. 2019. &lt;https://www.medicalnewstoday.com/articles/325694.php&gt;</p><hr size="1" /><p><strong>APA</strong><br />Slowiczek, L. (2019, August 15). "Zytiga (abiraterone acetate)." <i>Medical News Today</i>. Retrieved from<br><a href='https://www.medicalnewstoday.com/articles/325694.php' itemprop='url'>https://www.medicalnewstoday.com/articles/325694.php</a>.</p><hr size="1" /><p>Please note: If no author information is provided, the source is cited instead.</p>	</ul>
	                                </div>
                            </div>
                        </div>

                    </div>


					
	<hr class="nonprint"/>
<div class="article_email">
	<div id="header_close_button" class="email_close"></div>
	<div class="emailform_container">

	</div>
</div></div>  
</article>

	<div class="col-xs-12 col-sm-12 col-md-4 col-lg-4 sidebar"> 
<!-- article_ad code -->
<!-- MREC ARTICLE advert -->
<div id="dmr1_container" class="mnt css_hs211">

<div class="mnt_history" style="display:none;">
	<a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_knowledge_center_001.png" alt="MNT Knowledge Center" /></a>
 	

</div>

		<div id='dmr1_unit' adonis-marker>
		<script type='text/javascript'>
			googleAdSlotInfo.push({
				"slotName":'DMR1',
				"slotContainer":'dmr1_container'			});
		</script>
		</div>
		<span class='bt-uid-tg' data-uid='5b84643d24-160' style='display: none !important'></span></div> <!-- /article_ad code -->
	<div id="sidebar_feature" class="full">
			<h2>Latest news</h2>
		<span></span>
	<ul class="sidebar_feature">
	<li>	<a href="/articles/326281.php" title="Curiosities of medical history: Trepanation">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326281/326281_1100.jpg" alt="Curiosities of medical history: Trepanation" class="original">
	<div class="headline">Curiosities of medical history: Trepanation</div> 
	<div class="excerpt">Trepanation is the historical practice of drilling holes into the skull. But why did our ancestors do it, and when did it start? We investigate.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326278.php" title="Scientists identify genetic components of left-handedness">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326278/326278_1100.jpg" alt="Scientists identify genetic components of left-handedness" class="original">
	<div class="headline">Scientists identify genetic components of left-handedness</div> 
	<div class="excerpt">In a genetic analysis of 400,000 people, scientists have, for the first time, identified four DNA regions associated with left-handedness.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326243.php" title="World first: Doctors use 'reprogrammed' stem cells to repair cornea">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326243/326243_1100.jpg" alt="World first: Doctors use 'reprogrammed' stem cells to repair cornea" class="original">
	<div class="headline">World first: Doctors use 'reprogrammed' stem cells to repair cornea</div> 
	<div class="excerpt">In a groundbreaking procedure, surgeons have successfully repaired a human cornea using 'reprogrammed' cells from the patient's skin. </div>
	</div>

	</a></li>
	<li>	<a href="/articles/326232.php" title="Inflammation in late teens linked to mortality risk decades later">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326232/326232_1100.jpg" alt="Inflammation in late teens linked to mortality risk decades later" class="original">
	<div class="headline">Inflammation in late teens linked to mortality risk decades later</div> 
	<div class="excerpt">Experts know little about how inflammation in early life affects health later on. A new study links teen inflammation to mortality risk 35 years later.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326271.php" title="Scientists identify a trigger for type 1 diabetes in mice">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326271/326271_1100.jpg" alt="Scientists identify a trigger for type 1 diabetes in mice" class="original">
	<div class="headline">Scientists identify a trigger for type 1 diabetes in mice</div> 
	<div class="excerpt">Scientists discover a previously unknown switch that causes immune cells to begin destroying insulin, resulting in the onset of type 1 diabetes. </div>
	</div>

	</a></li>
		</ul>
	</div>
		<!-- article_ad code -->
<!-- MREC ARTICLE advert -->
<div id="dmr2_container" class="mnt css_hs211">

<div class="mnt_history" style="display:none;">
	<a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_knowledge_center_001.png" alt="MNT Knowledge Center" /></a>
 	

</div>

		<div id='dmr2_unit' adonis-marker>
		<script type='text/javascript'>
			googleAdSlotInfo.push({
				"slotName":'DMR2',
				"slotContainer":'dmr2_container'			});
		</script>
		</div>
		<span class='bt-uid-tg' data-uid='5b846454f2-160' style='display: none !important'></span></div> <!-- /article_ad code -->
	<div class="full popular_tabs_container"> 	<div class="full popular_tabs_parent"> 	<h2 class="popular_tabs_heading"><span>Popular in: </span>Prostate / Prostate Cancer</h2><span></span>
	<div id="popular_tabs">
	<div class="centered">
	
	<ul class="nav">
		</ul>
	
			<div class="list-wrap">
					<ul id="popular-read">
				<li class="knowledge">
	<a href="/articles/323792.php" title="What are the most common causes of pelvic pain in men?">
		<span class="headline">
	What are the most common causes of pelvic pain in men?	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/323737.php" title="What are bone metastases in prostate cancer?">
		<span class="headline">
	What are bone metastases in prostate cancer?	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/324480.php" title="What to expect from Lupron treatment">
		<span class="headline">
	What to expect from Lupron treatment	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/323899.php" title="PSA levels after prostatectomy">
		<span class="headline">
	PSA levels after prostatectomy	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/323954.php" title="Prostate cancer and back pain">
		<span class="headline">
	Prostate cancer and back pain	</span>
		</a></li>
				<span></span> 			</ul>
					</div> <!-- /list_wrap -->
			</div> <!-- /the_tabs -->
	</div> <!-- /centered -->
	</div> 	</div> 	</div> <!-- /sidebar -->
</div> 
</div> 


	<img height="1" width="1" src="https://d.turn.com/r/dd/id/L21rdC84MTYvY2lkLzE3NDc2NjAwNjEvdC8y/kv/CampaignID=MedicalNewsToday,Content=prostatecancer">

<div id="message"><a href="#top" style="display: none;">Scroll to top</a></div>


<footer>

<div class="container">

	<div class="row"> 	
		<div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 footer"> 		
			<div id="footer_logo">
				<a href="/"  title="Medical News Today : Home">
					<img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-mini-2017.png" alt="MNT home">
				</a>
			</div> 				
			<div id="footer_social">
				<span class="footer_facebook fa-stack fa-lg">
				<a href="https://www.facebook.com/MedicalNewsToday" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-facebook fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_twitter fa-stack fa-lg">
				<a href="https://twitter.com/mnt" target="_blank" rel="noopener noreferrer">
				<i class="fa fa-twitter fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_linkedin fa-stack fa-lg">
				<a href="https://www.linkedin.com/company/mednewstoday" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-linkedin fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_pinterest fa-stack fa-lg">
				<a href="https://www.pinterest.com/search/pins/?q=www.medicalnewstoday.com" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-pinterest fa-stack-1x fa-inverse"></i>
				</a></span>
			</div> 		
			<div id="footer_list">
				<ul>
								<li><a href="/popular" title="View our most popular news articles">Popular news</a></li>
				<li><a href="/archive" title="View all our editorial articles">Editorial articles</a></li>
				<li><a href="/categories" accesskey="m" title="View our complete news category list">All news topics</a></li>
				<li><a href="/knowledge-center" title="Medical conditions and information center">Knowledge center</a></li>

								<li><a href="/newsletter" title="Medical News Today in your inbox">Newsletters</a></li>


					
				<li><a href="/share-our-content" title="Share our content">Share our content</a></li>

								<li><a href="/about" title="About Medical News Today">About us</a></li>
				<li><a href="/authors" title="Our editorial team">Our editorial team</a></li>
				<li><a href="/contact" title="Contact the Medical News Today team">Contact us</a></li>
				<li><a href="/advertising" title="Advertise with Medical News Today">Advertise with MNT</a></li>
				</ul>
			</div> 				
			<span class="footer_separator">
				<span></span>
			</span> 			
			<div id="footer_newsletter">
					<h3 id="footer_newsletter_h3">get our newsletter</h3>
					<span id="footer_newsletter_span">Health tips, wellness advice and more.</span>
					
					<div class="form-group">
						<form method="post" action="#" name="footerNewsletterSignup" id="footerNewsletterSignup" class="newsletterForm">
						<div>
							<input type="text" name="formEmail" id="EmailAddress" class="newsletterFormEmail" placeholder="Enter your email address" size="25" maxlength="150"/>

							<button type="button"
									data-signup-source="footer_newsletter_link"
									class="btn btn-success btn-lg btn-block btn-footer footer_newsletter_link email-signup-btn new_reg_signup">Subscribe</button>

							<div id="footerNewsletterErrorHolder" class="errorHolder"></div>
							

<p>Your <a href="/privacy-policy" title="Privacy policy">privacy</a> is important to us.</p>

						</div>


						</form>

					</div> 				
			</div> 			
			<span class="footer_separator">
				<span></span>
			</span> 			
			<div id="copyright">
				<div class="honcode_img">
				<a href="https://www.healthonnet.org/HONcode/Conduct.html?HONConduct391155" class="seal" onclick="window.open(this.href); return false;">
				<img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://www.honcode.ch/HONcode/Seal/HONConduct391155_s1.gif" alt="This website is certified by Health On the Net Foundation. Click to verify."></a>
				</div> 				<div class="copyright_text float_left">
					<p>Healthline Media UK Ltd, Brighton, UK.</p>
					<p>&copy; 2004-2019 All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.</p>
				</div> 				<div class="copyright_text float_right">
					<p><a href="/privacy-policy" title="View our privacy policy" onclick="fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'New Header - Desktop - Footer', eventAction: 'Footer - Privacy policy', eventLabel: 'Footer - Privacy policy' });});" >Privacy</a> |
					<a href="/terms" title="View our terms of use" onclick="fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'New Header - Desktop - Footer', eventAction: 'Footer - Terms', eventLabel: 'Footer - Terms' });});">Terms</a> |
					<a href="/ad-policy" title="View our advertising policy">Ad policy</a> | 
					<a href="https://www.healthline.com/health/careers" title="Careers" rel="noopener" target="_blank">Careers</a></p>
				</div> 			</div> 			
			<div class="footer_truste_container">
				<div class="footer_truste"><a href="//privacy.truste.com/privacy-seal/validation?rid=b59e7a69-59cd-449f-9af4-2bdba7d346e5" rel="noopener noreferrer" target="_blank"><img style="border: none" src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="//privacy-policy.truste.com/privacy-seal/seal?rid=b59e7a69-59cd-449f-9af4-2bdba7d346e5" alt="TRUSTe"></a></div>
			</div> 			
		</div> 	
				
	</div> 
</div> 
<footer>

<div id="print_message">
	<p>This page was printed from: <strong><a href="https://www.medicalnewstoday.com/articles/325694.php">https://www.medicalnewstoday.com/articles/325694.php</a></strong></p>
	<p>Visit <strong><a href="https://www.medicalnewstoday.com">www.medicalnewstoday.com</a></strong> for medical news and health news headlines posted throughout the day, every day.</p>
	<hr/>
	<p>2019 Healthline Media UK Ltd. All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.</p>
</div> 



<script type="text/javascript">
		eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};if(!''.replace(/^/,String)){while(c--){d[e(c)]=k[c]||e(c)}k=[function(e){return d[e]}];e=function(){return'\\w+'};c=1};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('3 j=d.1i(\'.A-1p 8\');4(j&&j.c("b-7")){j.7=j.c("b-7");j.1r(\'b-7\')}3 9=[].v.w(d.o(\'8[b-7]\'));3 Q=5(q,g){4(q.g==""){q.g=g}B{3 1d=q.g.1s(" ");4(1d.u(g)==-1){q.g+=" "+g}}};1j(3 i=0;i<9.L;i++){4(9[i].1e.1e.p[0]==\'1n\'){Q(9[i],"A-f")}B{Q(9[i],"f")}}d.m("1t",5(){9=[].v.w(d.o(\'8.A-f\'));9.t(5(2){2.7=2.c("b-7");2.p.D("A-f")});9=[].v.w(d.o(\'8.f\'));3 16=18 6!=="1D";3 13=16&&!("1x"n 6)||/(1w|1y|1z)1E|1A|1H/i.1G(1I.1l);4(13){9.t(5(2){2.7=2.c("b-7");2.p.D("f")})}B{4("V"n 6){4(\'F\'n 6&&\'X\'n 6.F.J&&!(\'O\'n F.J)){1C.1q(6.F.J,\'O\',{1B:5(){1h l.X>0}})}3 G=1F V(5(Y,1v){Y.t(5(S){4(S.O){3 2=S.N;2.p.D("f");2.7=2.c("b-7");M(2);G.1m(2)}})},{1k:"T T 1u T"});9.t(5(2){G.1o(2)})}B{3 y;5 h(){9=[].v.w(d.o(\'.f\'));4(y){1Q(y)}y=2g(5(){3 2k=6.2d;9.t(5(8){4((8.W().27-2c<=6.2l&&8.W().2b>=0)&&2a(8).29!=="26"){8.7=8.c("b-7");8.p.D(\'f\');M(8)}});4(9.L==0){d.U("12",h);6.U("11",h);6.U("10",h)}},20)}h();d.m("12",h);6.m("11",h);6.m("10",h)}5 M(2){2.1J=5(){4(2.c(\'b-I-2-x\')){28(2.c(\'b-I-2-x\'),"",R)}4(2.c(\'b-Z-2-x\')){2e(2.c(\'b-Z-2-x\'),"",1a)}}}}3 K=d.o(\'.2j a:2i(.2h)\');1j(3 E=0;E<K.L;E++){3 C=K[E];4(C.s.u(6.1b.s)===-1&&C.s!=""){C.m("I",5(e){4(e.N.g.u("2-2f")>-1){1h 1f}e.24();3 k=l.s;3 P="17 1g - 25 14 15";3 1c=k;3 H=l.1R;3 z=l.1i("8");4(z){H=z.1S||z.1P}3 r=1f;4(18 k!=="1O"&&k.u("1K.1L")===-1){r=R;P="17 1g - 1M 14 15"}4(l.N==="1N"){r=R}4(r){3 19=6.1T(k);19.1U=1a}21(0,5(){22(\'23\',\'1Z\',{1Y:P,1V:H,1W:1c,1X:5(){4(!r){6.1b.s=k}}})})})}}});',62,146,'||image|var|if|function|window|src|img|lazyloadImages||data|getAttribute|document||lazy|className|lazyload||owlCarouselFirstImage|originHref|this|addEventListener|in|querySelectorAll|classList|element|newWindow|href|forEach|indexOf|slice|call|index|lazyloadThrottleTimeout|imageDom|owl|else|linkDOM|remove|articleIndex|IntersectionObserverEntry|imageObserver|gaAction|click|prototype|linksInArticle|length|includeImagePlugin|target|isIntersecting|gaCategory|addLazyClass|true|entry|0px|removeEventListener|IntersectionObserver|getBoundingClientRect|intersectionRatio|entries|sharing|orientationChange|resize|scroll|isBot|Link|Click|runningOnBrowser|Article|typeof|newWnd|null|location|gaLabel|arr|parentNode|false|Body|return|querySelector|for|rootMargin|userAgent|unobserve|item|observe|carousel|defineProperty|removeAttribute|split|DOMContentLoaded|300px|observer|gle|onscroll|ing|ro|crawl|get|Object|undefined|bot|new|test|spider|navigator|onload|medicalnewstoday|com|Outbound|_blank|undefiend|alt|clearTimeout|innerHTML|title|open|opener|eventAction|eventLabel|hitCallback|eventCategory|event||fireOrSaveJsFunctions|ga|send|preventDefault|Internal|none|top|loadClickableImageByIndex|display|getComputedStyle|bottom|300|pageYOffset|loadImageSharingImageByIndex|clickable|setTimeout|collapsed__click|not|article_body|scrollTop|innerHeight'.split('|'),0,{}))

</script>
<script type="text/javascript">
	window.ga=window.ga||function(){};
	if (typeof window.googletag === 'undefined') {
		//Fallback safe for googletag
    	var googletag = googletag || { };
		googletag.cmd = googletag.cmd || [ ];
	}
	
	//Fallback for Adbridg
	if (typeof window.AdBridg === 'undefined') {
		var AdBridg = AdBridg || {};
  		AdBridg.cmd = AdBridg.cmd || [];
	}

</script>







<script type="text/javascript">



		vanillaAjax("https://pavlov-prod.healthline.com/api/metrics","POST",'{"metrics":[{"type":"increment","name":"ui.pageview"}],"build":"1","route":"php","path":"/articles/325694.php","formfactor":"desktop","site":"mnt","abSegment":""}','{"Content-Type":"text\/plain;charset=UTF-8"}');






</script>


<script type="text/javascript" >
			var is_userMobile=0;
			var is_userTablet=0;
			var glob_responsiveOverride=0;
			var glob_customUserID=0;
			var category=[{"displayNavName":"ADHD \/ ADD","url":"adhd"},{"displayNavName":"Allergy","url":"allergy"},{"displayNavName":"Alzheimer's \/ Dementia","url":"alzheimers"},{"displayNavName":"Anxiety \/ Stress","url":"anxiety"},{"displayNavName":"Rheumatology","url":"rheumatology"},{"displayNavName":"Respiratory","url":"respiratory"},{"displayNavName":"Bipolar","url":"bipolar"},{"displayNavName":"Body Aches","url":"bodyaches"},{"displayNavName":"Breast Cancer","url":"breast_cancer"},{"displayNavName":"Cancer \/ Oncology","url":"cancer-oncology"},{"displayNavName":"Cardiovascular \/ Cardiology","url":"cardiovascular"},{"displayNavName":"Caregivers \/ Homecare","url":"caregivers"},{"displayNavName":"Cholesterol","url":"cholesterol"},{"displayNavName":"Crohn's","url":"crohns"},{"displayNavName":"Cystic Fibrosis","url":"cystic_fibrosis"},{"displayNavName":"Depression","url":"depression"},{"displayNavName":"Dermatology","url":"dermatology"},{"displayNavName":"Diabetes","url":"diabetes"},{"displayNavName":"Erectile Dysfunction","url":"erectile_dysfunction"},{"displayNavName":"Fertility","url":"fertility"},{"displayNavName":"Obesity \/ Weight Loss \/ Fitness","url":"fitness-obesity"},{"displayNavName":"Headache \/ Migraine","url":"headache-migraine"},{"displayNavName":"Liver Disease \/ Hepatitis","url":"liver_disease"},{"displayNavName":"HIV and AIDS","url":"hiv-aids"},{"displayNavName":"Hypertension","url":"hypertension"},{"displayNavName":"Irritable Bowel Syndrome","url":"ibs"},{"displayNavName":"Lung Cancer","url":"lung_cancer"},{"displayNavName":"Lymphoma","url":"lymphoma"},{"displayNavName":"Men's Health","url":"mens_health"},{"displayNavName":"Mental Health","url":"mental_health"},{"displayNavName":"Neurology \/ Neuroscience","url":"neurology"},{"displayNavName":"Pregnancy \/ Obstetrics","url":"pregnancy"},{"displayNavName":"Psychology \/ Psychiatry","url":"psychology-psychiatry"},{"displayNavName":"Schizophrenia","url":"schizophrenia"},{"displayNavName":"Seniors \/ Aging","url":"seniors"},{"displayNavName":"Sexual Health \/ STDs","url":"sexual_health"},{"displayNavName":"Statins","url":"statins"},{"displayNavName":"Urology \/ Nephrology","url":"urology-nephrology"},{"displayNavName":"Women's Health","url":"womens_health"},{"displayNavName":"Pediatrics \/ Children's Health","url":"pediatrics"},{"displayNavName":"Radiology \/ Nuclear Medicine","url":"radiology"},{"displayNavName":"Bones \/ Orthopedics","url":"bones"},{"displayNavName":"Public Health","url":"public_health"},{"displayNavName":"Bio-terrorism \/ Terrorism","url":"bioterrorism"},{"displayNavName":"Aid \/ Disasters","url":"aid-disasters"},{"displayNavName":"Genetics","url":"genetics"},{"displayNavName":"Ear, Nose and Throat","url":"ent"},{"displayNavName":"Alcohol \/ Illegal Drugs","url":"alcohol"},{"displayNavName":"Nursing \/ Midwifery","url":"nursing"},{"displayNavName":"Medical Students \/ Training","url":"medical_students"},{"displayNavName":"Pharma \/ Biotech Industry","url":"pharma_industry"},{"displayNavName":"Stem Cell Research","url":"stem_cell"},{"displayNavName":"Dentistry","url":"dentistry"},{"displayNavName":"Bird Flu \/ Avian Flu","url":"birdflu"},{"displayNavName":"MRSA \/ Drug Resistance","url":"mrsa-superbug"},{"displayNavName":"Eye Health \/ Blindness","url":"eye_health"},{"displayNavName":"Tropical Diseases","url":"tropical_diseases"},{"displayNavName":"Cleft Palate","url":"cleft_palate"},{"displayNavName":"Infectious Diseases","url":"infectious_diseases"},{"displayNavName":"Parkinson's Disease","url":"parkinsons_disease"},{"displayNavName":"GastroIntestinal","url":"gastrointestinal"},{"displayNavName":"CJD \/ vCJD \/ Mad Cow Disease","url":"cjd-vcjd"},{"displayNavName":"Nutrition \/ Diet","url":"nutrition-diet"},{"displayNavName":"Gout","url":"gout"},{"displayNavName":"Stroke","url":"stroke"},{"displayNavName":"Complementary Medicine","url":"complementary_medicine"},{"displayNavName":"Endocrinology","url":"endocrinology"},{"displayNavName":"Biology \/ Biochemistry","url":"biology-biochemistry"},{"displayNavName":"Multiple Sclerosis","url":"multiple_sclerosis"},{"displayNavName":"Autism","url":"autism"},{"displayNavName":"Water - Air Quality \/ Agriculture","url":"water_quality"},{"displayNavName":"Immune System \/ Vaccines","url":"immune_system"},{"displayNavName":"Lupus","url":"lupus"},{"displayNavName":"Cosmetic Medicine","url":"cosmetic_medicine"},{"displayNavName":"Rehabilitation","url":"rehabilitation"},{"displayNavName":"Pain \/ Anesthetics","url":"pain"},{"displayNavName":"Hearing \/ Deafness","url":"hearing-deafness"},{"displayNavName":"Muscular Dystrophy \/ ALS","url":"muscular_dystrophy"},{"displayNavName":"Sports Medicine \/ Fitness","url":"sports_medicine"},{"displayNavName":"MRI \/ PET \/ Ultrasound","url":"mri-pet"},{"displayNavName":"Huntingtons Disease","url":"huntingtons_disease"},{"displayNavName":"Medical Devices \/ Diagnostics","url":"medical_devices"},{"displayNavName":"Smoking \/ Quit Smoking","url":"smoking"},{"displayNavName":"Transplants \/ Organ Donations","url":"transplants"},{"displayNavName":"Sleep \/ Sleep Disorders","url":"sleep"},{"displayNavName":"IT \/ Internet \/ E-mail","url":"it"},{"displayNavName":"Dyslexia","url":"dyslexia"},{"displayNavName":"Medicare \/ Medicaid \/ SCHIP","url":"medicare-medicaid"},{"displayNavName":"Epilepsy","url":"epilepsy"},{"displayNavName":"Prostate \/ Prostate Cancer","url":"prostate"},{"displayNavName":"Veterinary","url":"veterinary"},{"displayNavName":"Abortion","url":"abortion"},{"displayNavName":"Health Insurance","url":"health_insurance"},{"displayNavName":"Litigation","url":"medical_malpractice"},{"displayNavName":"Clinical Trials \/ Drug Trials","url":"clinical_trials"},{"displayNavName":"Conferences","url":"conferences"},{"displayNavName":"Compliance","url":"compliance"},{"displayNavName":"Primary Care \/ General Practice","url":"primary_care"},{"displayNavName":"Flu \/ Cold \/ SARS","url":"flu-sars"},{"displayNavName":"Blood \/ Hematology","url":"blood"},{"displayNavName":"Colorectal Cancer","url":"colorectal_cancer"},{"displayNavName":"Acid Reflux \/ GERD","url":"gerd"},{"displayNavName":"Cervical Cancer \/ HPV Vaccine","url":"cervical_cancer"},{"displayNavName":"Eating Disorders","url":"eatingdisorders"},{"displayNavName":"Pharmacy \/ Pharmacist","url":"pharmacy"},{"displayNavName":"Regulatory Affairs","url":"regulatoryaffairs"},{"displayNavName":"Ovarian Cancer","url":"ovarian_cancer"},{"displayNavName":"Menopause","url":"menopause"},{"displayNavName":"Psoriasis","url":"psoriasis"},{"displayNavName":"Tuberculosis","url":"tuberculosis"},{"displayNavName":"Back Pain","url":"back-pain"},{"displayNavName":"Heart Disease","url":"heart-disease"},{"displayNavName":"Asbestos \/ Mesothelioma","url":"asbestos"},{"displayNavName":"Lymphology \/ Lymphedema","url":"lymphology"},{"displayNavName":"Veterans \/ Ex-Servicemen","url":"veterans"},{"displayNavName":"Medical Practice Management","url":"medical_practice"},{"displayNavName":"Melanoma \/ Skin Cancer","url":"melanoma"},{"displayNavName":"COPD","url":"copd"},{"displayNavName":"Palliative Care \/ Hospice Care","url":"palliative_care"},{"displayNavName":"Vascular","url":"vascular"},{"displayNavName":"Fibromyalgia","url":"fibromyalgia"},{"displayNavName":"Pancreatic Cancer","url":"pancreatic-cancer"},{"displayNavName":"Preventive Medicine","url":"preventive-medicine"},{"displayNavName":"Swine Flu","url":"swine-flu"},{"displayNavName":"Restless Legs Syndrome","url":"restless-legs"},{"displayNavName":"Food Intolerance","url":"food-intolerance"},{"displayNavName":"Personal Monitoring","url":"personal-monitoring"},{"displayNavName":"Surgery","url":"surgery"},{"displayNavName":"Emergency Medicine","url":"emergency-medicine"},{"displayNavName":"Pulmonary System","url":"pulmonary-system"},{"displayNavName":"Medical Innovation","url":"medical-innovation"},{"displayNavName":"Ebola","url":"ebola"},{"displayNavName":"Ulcerative Colitis","url":"ulcerative-colitis"},{"displayNavName":"Constipation","url":"constipation"},{"displayNavName":"Arrhythmia","url":"arrhythmia"},{"displayNavName":"Osteoporosis","url":"osteoporosis"},{"displayNavName":"Diabetes Type 1","url":"diabetes-type-1"},{"displayNavName":"Diabetes Type 2","url":"diabetes-type-2"},{"displayNavName":"Dry Eye","url":"dry-eye"},{"displayNavName":"Endometriosis","url":"endometriosis"},{"displayNavName":"Psoriatic Arthritis","url":"psoriatic-arthritis"},{"displayNavName":"Hypothyroid","url":"hypothyroid"},{"displayNavName":"Shingles","url":"shingles"},{"displayNavName":"Premature Ejaculation","url":"premature-ejaculation"},{"displayNavName":"Asthma","url":"asthma"},{"displayNavName":"VTE","url":"vte"},{"displayNavName":"Seasonal Allergy","url":"seasonal-allergy"},{"displayNavName":"Food Allergy","url":"food-allergy"},{"displayNavName":"OAB","url":"oab"},{"displayNavName":"Urinary Tract Infection","url":"urinary-tract-infection"},{"displayNavName":"Leukemia","url":"leukemia"},{"displayNavName":"Osteoarthritis","url":"osteoarthritis"},{"displayNavName":"Rheumatoid Arthritis","url":"rheumatoid-arthritis"},{"displayNavName":"Birth Control","url":"birth-control-contraception"},{"displayNavName":"Head and Neck Cancer","url":"head-and-neck-cancer"},{"displayNavName":"Atopic Dermatitis","url":"atopic-dermatitis-eczema"},{"displayNavName":"Bites and Stings","url":"bites-stings"}];
			var glob_testServer = 0;
			var resetpw = 0;
			var glob_newSkin = 1;
			var glob_menu_prefix = 'New Header';
			var glob_deviceInfo = 'Desktop';
			var glob_newRegistration = 1;
			var glob_triggerSurvey = 0;
			var glob_pageType = 'article';
			var glob_siteRevision = 7721;
			var showNewsletterPopup = 1;
			var showFocusGroupPopup = 0;
			</script>



							<script type="text/javascript" src="https://cdn-prod.medicalnewstoday.com/structure/javascript/out/mnt_default.js?v=190904" defer></script>
				
		<script src="https://healthline-com.videoplayerhub.com/galleryloader.js" defer></script>

	




<script type="text/javascript">

	fireOrSaveJsFunctions(1,function(){

		var tempAacctTid =setInterval(function() {

			if(typeof _qevents !== "undefined"){
				//wait until _qevents had been set
				_qevents.push( { qacct:"p-v03RmX3GES6RT"} );
				clearInterval(tempAacctTid);
			}

		}, 500);

	});

</script>
<noscript>
	<div style="display: none;">
		<img src="https://pixel.quantserve.com/pixel/p-test123.gif" height="1" width="1" alt="Quantcast"/>
	</div>
</noscript>


<script src="https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/oct.js" type="text/javascript"></script>
<script type="text/javascript">

	fireOrSaveJsFunctions(1,function(){
		twttr.conversion.trackPid('l4bfr');
	});

</script>
<noscript>
	<img height="1" width="1" style="display:none;" alt="" src="https://analytics.twitter.com/i/adsct?txn_id=l4bfr&p_id=Twitter" />
</noscript>



<div id="fb-root"></div>
<script>


	fireOrSaveJsFunctions(1,function(){

		(function(d, s, id) {
  var js, fjs = d.getElementsByTagName(s)[0];
  if (d.getElementById(id)) return;
  js = d.createElement(s); js.id = id;
  js.src = "//connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.3&appId=147184211975697";
  fjs.parentNode.insertBefore(js, fjs);
		}(document, 'script', 'facebook-jssdk'));

	});


</script>






<script>
	glob_categoryID="92";glob_categoryName="Prostate / Prostate Cancer category";glob_bindingK1="otherprostateproblems";</script>



<div id="amzn-assoc-ad-c3555b57-ee3e-4ba5-b6f4-ec40911af7e4"></div>
<script>

	fireOrSaveJsFunctions(1,function(){loadScript(
		"//z-na.amazon-adsystem.com/widgets/onejs?MarketPlace=US&adInstanceId=c3555b57-ee3e-4ba5-b6f4-ec40911af7e4",
		{},
		function(){}

	)});

</script>


	<script>
		// 1. create object of script
		var deferCSS = document.createElement('script');
		deferCSS.src = 'https://hello.myfonts.net/count/333229';
		deferCSS.type = 'text/javascript';
		deferCSS.defer = true;

		// 2. declaire position of </body>
		var deferCSS_place = document.getElementsByTagName('body')[0];

		// 3. insert object before </body>
		deferCSS_place.appendChild(deferCSS);
	</script>




<!-- Begin medicalnewstoday.com BlueKai Tag --> 
<script type="text/javascript"> 
window.bk_async = function() { 
	bk_addPageCtx('categoryMain', 'prostate');
	bk_addPageCtx('categorySub', '');
	bk_addPageCtx('dimension28', 'prostatecancer');
	bk_addPageCtx('dimension29', 'cancer');
	BKTAG.doTag(76945, 10);
}; 
(function() { 
	var scripts = document.getElementsByTagName('script')[0]; 
	var s = document.createElement('script'); 
	s.async = true; 
	s.src = "https://tags.bkrtx.com/js/bk-coretag.js"; 
	scripts.parentNode.insertBefore(s, scripts); 
}()); 
</script> 
<!-- End BlueKai Tag --> 




<script type="text/javascript" >
				var articleID="325694";
				var articleType = "drugs";
				var emailID = "325694";
				var articleURL = "/articles/325694.php";
				var threadID = "0";
				var opinionsOutput = 0;
				var showAdsOnArticle = 1;
				var isSponsored = 0;
				</script>
    <script type="text/javascript">
    
		for(var contentBlocksDoms=document.querySelectorAll(".infobox_large.article-tcblocks > li"),i=0;i<contentBlocksDoms.length;i++){var _this=contentBlocksDoms[i],mobileHeadline=_this.querySelector("a  > div.headline.mobile"),excerpt=_this.querySelector("a > div > .excerpt"),desktopHeadlineHtmlStr=mobileHeadline.outerHTML;desktopHeadlineHtmlStr=desktopHeadlineHtmlStr.replace(/(class=\".*?)\s*mobile\s*(.*?\")/g,"$1$2"),null===_this.querySelector("a > div > .headline")&&excerpt.insertAdjacentHTML("beforebegin",desktopHeadlineHtmlStr),_this.getElementsByTagName("a")[0].removeChild(mobileHeadline)}

		//Remove  class hide in tabbed content to show on desktop/ tablet
		if(document.getElementsByClassName("collapsed__tabs")[0]){
			document.getElementsByClassName("collapsed__tabs")[0].classList.remove('hide');	
		}

    </script>



	<script type="text/javascript">

		var articleTOC = document.getElementsByClassName("article_toc")[0];

		if(document.body.contains(articleTOC)){
			// if the page contains article TOC, we do the trick
			var articleTOCpreviousElement = articleTOC.previousElementSibling;

			if(articleTOCpreviousElement){
				if((articleTOCpreviousElement.className.indexOf("photobox_header") !==-1&&articleTOCpreviousElement.querySelector("em") != null)||(articleTOCpreviousElement.className.indexOf("photobox_left") !==-1&&articleTOCpreviousElement.querySelector("em") != null)||(articleTOCpreviousElement.className.indexOf("photobox_right") !==-1&&articleTOCpreviousElement.querySelector("em") != null)){
					articleTOC.classList.add("article_collapsed--top");
				}
			}

		}

	</script>



	<input type="hidden" id="newsid" name="newsid" value="325694">
	<input type="hidden" id="categoryid" name="categoryid" value="92">
	<input type="hidden" id="glob" name="glob" value="0">
	<input type="hidden" id="ratingHCP" name="ratingHCP" value="0">
	<input type="hidden" id="ratingPublic" name="ratingPublic" value="0">
	<input type="hidden" id="alreadyRated" name="alreadyRated" value="0">
	<input type="hidden" id="kcarticle" name="kcarticle" value="0">
	<input type="hidden" id="bottomRatingsBoxReadOnly" name="bottomRatingsBoxReadOnly" value="true">
		
	
				<script type="text/javascript" src="https://cdn-prod.medicalnewstoday.com/structure/javascript/out/mnt_article_7721.js" defer></script>
		

		




<script type="text/javascript">
var mntDataLayer = "";
//Fire in adblock.js cause that's the last event in the page 
function setMNTDataLayer(e) {
	mntDataLayer = {"article_meta":{"publisher":"Medical News Today","headline":"Zytiga (abiraterone acetate)","description":"Zytiga (abiraterone acetate) is a brand-name prescription medication. It\u2019s used to treat two types of prostate cancer: metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC). Zytiga comes as a tablet. Learn about side effects, cost, dosage, and more.","url":"\/articles\/325694.php","CanonicalURL":"https:\/\/www.medicalnewstoday.com\/articles\/325694.php","datePublished":"2019-08-15","dateUpdated":"","dateReviewed":"2019-06-23","author":"Lindsay Slowiczek, PharmD","coAuthor":"","reviewer":"Victor Nguyen, PharmD, MS","ratingHCP":0,"ratingPublic":0,"commentCount":0,"shareCountFacebook":0,"shareCountGooglePlus":0,"shareCountLinkedIn":0,"shareCountPinterest":0,"ampURL":"","ampVersion":"N"},"reader":{"loggedIn":"no"},"targeting":{"categoryMain":"prostate","categorySub":[""],"articleKeywords":"","articleID":"325694","articleType":"drugs","micrositeID":"zytigacdi","articleVersion":"v2","articleAge":"month"},"customDimensions":{"siteVersion":"desktop","webServer":-1,"iosAppTraffic":-1,"viewportWidth":0,"viewportHeight":0,"hidpi":0,"adblockStatus":0}}
	mntDataLayer["article_meta"]["shareCountFacebook"] 	 = facebookCount;
	mntDataLayer["article_meta"]["shareCountGooglePlus"] = googlePlusCount;
	mntDataLayer["article_meta"]["shareCountLinkedIn"] 	 = linkedinCount;
	mntDataLayer["article_meta"]["shareCountPinterest"]	 = pinterestCount;
	mntDataLayer["article_meta"]["url"]	 				 = window.location.href;
	mntDataLayer["customDimensions"]["adblockStatus"] 	 = adBlockValue;
 	mntDataLayer["customDimensions"]["viewportWidth"] = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);
 	mntDataLayer["customDimensions"]["viewportHeight"] = Math.max(document.documentElement.clientHeight, window.innerHeight || 0);
 	mntDataLayer["customDimensions"]["hidpi"] = (window.devicePixelRatio >= 1.5) ? "HiDPI" : "1X";
}
</script>

					
			
</div> </body>
</html>
